CN102858272B - Expansion device for treatment of vascular passageways - Google Patents
Expansion device for treatment of vascular passageways Download PDFInfo
- Publication number
- CN102858272B CN102858272B CN201080063892.XA CN201080063892A CN102858272B CN 102858272 B CN102858272 B CN 102858272B CN 201080063892 A CN201080063892 A CN 201080063892A CN 102858272 B CN102858272 B CN 102858272B
- Authority
- CN
- China
- Prior art keywords
- expansion device
- balloon
- balloon member
- expandable
- prosthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
- A61B2017/00783—Valvuloplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22098—Decalcification of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
技术领域 technical field
本公开涉及可用于治疗心脏瓣膜疾病的装置和方法,包括球囊瓣膜成形术和经导管心脏瓣膜的输送。The present disclosure relates to devices and methods useful in the treatment of heart valve disorders, including balloon valvuloplasty and transcatheter heart valve delivery.
背景技术 Background technique
心脏瓣膜疾病是一个严重的问题,其涉及心脏的一个或多个瓣膜的故障。该故障可以各种方式自己表现出来。例如,瓣膜狭窄是天然心脏瓣膜的钙化或变窄。结果,天然心脏瓣膜不能完全打开并且通过天然瓣膜的血流受阻或受限。心脏瓣膜疾病的另一个例子是瓣膜闭锁不全。瓣膜闭锁不全是天然心脏瓣膜失灵不能适当关闭以防止通过瓣膜血液渗漏或回流。Heart valve disease is a serious problem that involves the failure of one or more valves of the heart. This fault can manifest itself in various ways. For example, valvular stenosis is calcification or narrowing of the natural heart valves. As a result, the natural heart valve does not open fully and blood flow through the natural valve is blocked or restricted. Another example of heart valve disease is valvular insufficiency. Valvular insufficiency is the failure of the natural heart valves to close properly to prevent leakage or backflow of blood through the valves.
已经开发了各种方法以治疗心脏瓣膜疾病。一些这些方法需要在天然心脏瓣膜中膨胀的球囊元件。例如,球囊元件可用在瓣膜成形术手术中,其中球囊元件位于天然心脏瓣膜内并膨胀以增加天然心脏瓣膜的开口尺寸(即,流动面积)并从而改善血流。可实施的另一个手术是瓣膜置换,其中天然心脏瓣膜被人工心脏瓣膜置换。在心脏中植入人工心脏瓣膜也可包括在瓣膜环中膨胀球囊元件。例如,球囊元件可用于增加天然瓣膜的尺寸,然后植入人工瓣膜和/或它可用于膨胀人工瓣膜本身和使其展开。Various approaches have been developed to treat heart valve disease. Some of these methods require balloon elements that are inflated within the native heart valve. For example, balloon elements may be used in valvuloplasty procedures where the balloon element is positioned within a native heart valve and inflated to increase the opening size (ie, flow area) of the native heart valve and thereby improve blood flow. Another procedure that may be performed is valve replacement, in which the natural heart valve is replaced with an artificial heart valve. Implanting a prosthetic heart valve in the heart may also include expanding a balloon member in the valve annulus. For example, the balloon element can be used to increase the size of a natural valve before implanting a prosthetic valve and/or it can be used to inflate and expand the prosthetic valve itself.
但是,天然瓣膜或其他脉管通道(vascular passageway)内球囊元件的膨胀可暂时地阻止或限制血液流动经过通道。如果血流在通道中被阻止或限制过长时间,可发生严重的损伤或死亡。而且,在瓣膜置换的情况下,人工心脏瓣膜的放置可由于左心室中压力的积累而变得复杂。因此,瓣膜成形术和瓣膜置换手术,以及其他类似的使用可膨胀球囊元件的过程通常必须快速地进行和/或利用心脏起搏过程,以便球囊元件仅被膨胀短暂时间。However, inflation of the balloon element within the native valve or other vascular passageway can temporarily prevent or restrict blood flow through the passageway. Severe injury or death can occur if blood flow is blocked or restricted in the channel for too long. Also, in the case of valve replacement, placement of a prosthetic heart valve can be complicated by the buildup of pressure in the left ventricle. Accordingly, valvuloplasty and valve replacement procedures, and other similar procedures using inflatable balloon elements typically must be performed rapidly and/or utilize cardiac pacing procedures so that the balloon element is only inflated for a brief period of time.
发明内容 Contents of the invention
下列方法和装置涉及膨胀设备,其允许通过或围绕膨胀设备灌注血液。某些优选的实施方式涉及球囊元件,当球囊元件在通道中膨胀时,其允许通过或围绕球囊元件灌注血液。The following methods and devices relate to inflation devices that allow perfusion of blood through or around the inflation device. Certain preferred embodiments involve a balloon member that allows perfusion of blood through or around the balloon member when the balloon member is inflated in the channel.
在假体设备展开期间,在植入过程期间通过球囊元件阻塞通道——即使短时间段,可对医学过程引入并发症。在本文各种实施方式中描述的装置和方法可减少和/或基本上消除假体设备在其中膨胀期间通道的闭塞。During deployment of the prosthetic device, obstruction of the channel by the balloon element during the implantation procedure - even for a short period of time - can introduce complications to the medical procedure. The devices and methods described in various embodiments herein can reduce and/or substantially eliminate occlusion of a channel during expansion of a prosthetic device therein.
在本文各种实施方式中描述的装置和方法可允许更长的假体设备展开时间,消除对快速起搏心脏的需要和它的相关风险,以及允许在展开期间重新定位假体设备。The devices and methods described in various embodiments herein may allow longer prosthetic device deployment times, eliminate the need for a rapidly paced heart and its associated risks, and allow repositioning of the prosthetic device during deployment.
在第一种实施方式中,提供输送膨胀设备至治疗位置的系统。该系统包括具有远端的细长杆和膨胀设备,所述膨胀设备与细长杆的远端连接并在收缩构造和膨胀构造之间可移动。膨胀设备具有远端和近端,并且膨胀设备可包括内部可膨胀元件和多个外部可膨胀元件。多个外部可膨胀元件可至少部分围绕内部可膨胀元件。In a first embodiment, a system for delivering an expansion device to a treatment site is provided. The system includes an elongated rod having a distal end and an expansion device coupled to the distal end of the elongated rod and movable between a collapsed configuration and an expanded configuration. The expansion device has a distal end and a proximal end, and the expansion device may include an inner expandable element and a plurality of outer expandable elements. A plurality of outer expandable elements may at least partially surround the inner expandable element.
在具体实施中,内部可膨胀元件可独立于多个外部可膨胀元件膨胀。在其他具体实施中,多个外部可膨胀元件的一个或多个可独立于其他的多个外部可膨胀元件膨胀。在其他具体实施中,多个外部可膨胀元件没有相对于内部可膨胀元件的外表面在可膨胀元件的近端和远端之间的区域处固定。可选地,在其他具体实施中,多个外部可膨胀元件可被固定在可膨胀元件的近端和远端。In particular implementations, the inner expandable element is expandable independently of the plurality of outer expandable elements. In other implementations, one or more of the plurality of outer expandable elements is expandable independently of other of the plurality of outer expandable elements. In other implementations, the plurality of outer expandable elements are not fixed relative to the outer surface of the inner expandable element at a region between the proximal and distal ends of the expandable elements. Optionally, in other implementations, a plurality of outer expandable elements may be secured at the proximal and distal ends of the expandable elements.
在其他具体实施中,内部可膨胀元件可包括多个内部球囊元件。在其他具体实施中,当可膨胀元件处于它的膨胀构造时,至少一些外部可膨胀元件仅与一个内部球囊元件接触。In other implementations, the inner expandable member may comprise a plurality of inner balloon members. In other implementations, at least some of the outer expandable elements are in contact with only one inner balloon element when the expandable element is in its expanded configuration.
在其他具体实施中,内部可膨胀元件包括多个支柱,其具有近端和远端。支柱的近端和远端可从支柱的近端和远端进一步分开的第一方位可移动至支柱的近端和远端更靠近在一起的第二方位。在第一方位中,内部可膨胀元件处于收缩构造且在第二方位中内部可膨胀元件处于膨胀构造。In other implementations, the inner expandable member includes a plurality of struts having proximal and distal ends. The proximal and distal ends of the struts are movable from a first orientation in which the proximal and distal ends of the struts are further apart to a second orientation in which the proximal and distal ends of the struts are closer together. In the first orientation, the inner expandable element is in the collapsed configuration and in the second orientation the inner expandable element is in the expanded configuration.
在其他具体实施中,内部可膨胀元件可包括第一内部球囊和第二内部球囊元件。第一内部球囊元件比第二内部球囊元件可具有更小的膨胀直径。第一和第二内部球囊元件可基本上是彼此同轴的,并且第一和第二内部球囊元件可彼此独立地膨胀。In other implementations, the inner expandable member can include a first inner balloon member and a second inner balloon member. The first inner balloon member may have a smaller inflated diameter than the second inner balloon member. The first and second inner balloon members may be substantially coaxial with each other, and the first and second inner balloon members may be inflated independently of each other.
在其他具体实施中,假体设备可以以蜷曲构造提供,并且外部可膨胀元件可具有配置为接合假体设备的外表面。在其他具体实施中,假体设备可以是人工心脏瓣膜,其具有形成多个连合(commissure)的多个小叶,并且,以外部可膨胀元件与假体设备多个连合的一个或多个间隔开的方位,人工心脏瓣膜可配置为位于外部可膨胀元件的外表面上。In other implementations, the prosthetic device can be provided in a crimped configuration, and the outer expandable member can have an outer surface configured to engage the prosthetic device. In other implementations, the prosthetic device may be a prosthetic heart valve having leaflets forming a plurality of commissures, and one or more of the prosthetic device commissures with an outer expandable element. In a spaced orientation, the prosthetic heart valve can be configured to rest on an outer surface of the outer expandable member.
在其他具体实施中,内部可膨胀元件具有远端部、近端部和在远端和近端之间的中间部,并且,当内部可膨胀元件处于膨胀构造时,中间部的直径小于远端部的直径。在其他具体实施中,当可膨胀元件处于膨胀构造时,在邻近的外部可膨胀元件之间提供间隙。在其他具体实施中,内部可膨胀元件和外部可膨胀元件包括球囊元件。在其他具体实施中,灌注腔可延伸经过可膨胀元件的远端和近端之间的杆,从而在使用期间为血液通过可膨胀元件提供另外的通道。In other implementations, the inner expandable element has a distal end, a proximal end, and an intermediate portion between the distal and proximal ends, and the intermediate portion has a smaller diameter than the distal end when the inner expandable element is in the expanded configuration. the diameter of the section. In other implementations, gaps are provided between adjacent outer expandable elements when the expandable elements are in the expanded configuration. In other implementations, the inner expandable member and the outer expandable member comprise balloon members. In other implementations, a perfusion lumen may extend through the stem between the distal and proximal ends of the expandable element to provide additional passage for blood through the expandable element during use.
在另一种实施方式中,提供输送可膨胀元件至治疗位置的系统。该输送系统包括具有远端部的细长杆和可膨胀元件,所述可膨胀元件与细长杆的远端部连接并在收缩构造和膨胀构造之间可移动。可膨胀元件可具有远端和近端,并且可膨胀元件可包括从可膨胀元件的表面伸出的多个突出部分。当可膨胀元件处于膨胀构造时,多个突出部分可限定至少一个在可膨胀元件的远端和近端之间的通道。In another embodiment, a system for delivering an expandable element to a treatment site is provided. The delivery system includes an elongated shaft having a distal end and an expandable member coupled to the distal end of the elongated shaft and movable between a collapsed configuration and an expanded configuration. The expandable element may have a distal end and a proximal end, and the expandable element may include a plurality of protrusions protruding from a surface of the expandable element. The plurality of protrusions can define at least one channel between the distal end and the proximal end of the expandable element when the expandable element is in the expanded configuration.
在其他具体实施中,可膨胀元件可以是球囊元件。在其他具体实施中,至少一个通道可包括在可膨胀元件的远端和近端之间的至少一个纵向通道和至少一个圆周通道。在其他具体实施中,通道可包括在可膨胀元件的远端和近端之间的基本上螺旋的通道。在其他具体实施中,可膨胀元件可包括沿着可膨胀元件的长度具有大致圆形横截面的多个区域。In other implementations, the expandable member can be a balloon member. In other implementations, the at least one channel can include at least one longitudinal channel and at least one circumferential channel between the distal and proximal ends of the expandable element. In other implementations, the channel can comprise a substantially helical channel between the distal and proximal ends of the expandable element. In other implementations, the expandable element can include a plurality of regions having a generally circular cross-section along the length of the expandable element.
在另一种实施方式中,提供输送人工瓣膜经过患者脉管系统的装置。该装置包括主导管,其包括伸长的杆;和球囊导管,其具有伸长的杆,至少一个开口延伸通过杆的侧表面并且球囊元件与该杆的远端部连接。球囊导管的杆可以能够在主导管杆内纵向移动。球囊导管可包括延伸经过球囊导管至少一部分的灌注腔,该腔配置为当球囊元件处于膨胀状态时允许血液经过腔,血液经过球囊导管的杆中的开口。In another embodiment, an apparatus for delivering a prosthetic valve through the vasculature of a patient is provided. The device includes a main catheter including an elongated shaft; and a balloon catheter having an elongated shaft with at least one opening extending through a side surface of the shaft and a balloon member connected to the distal end of the shaft. The shaft of the balloon catheter may be movable longitudinally within the main catheter shaft. The balloon catheter may include a perfusion lumen extending through at least a portion of the balloon catheter, the lumen being configured to allow blood to pass through the lumen when the balloon member is in an inflated state, the blood passing through an opening in the shaft of the balloon catheter.
在其他具体实施中,在球囊元件下的至少部分的球囊导管(例如,在人工瓣膜的安装区域)可包括可收缩部分,其在减小腔直径的收缩状态和增加腔直径的膨胀状态之间可移动。在其他具体实施中,该腔可包括在球囊元件的近端和远端之间延伸的多个分开的通道。In other implementations, at least a portion of the balloon catheter under the balloon member (e.g., in the installation area of the prosthetic valve) can include a collapsible portion that operates in a deflated state that reduces the lumen diameter and an expanded state that increases the lumen diameter can be moved between. In other implementations, the lumen can include a plurality of separate channels extending between the proximal and distal ends of the balloon member.
在另一种实施方式中,提供输送可膨胀元件通过患者脉管系统的方法。该方法可包括在细长杆的远端提供可膨胀元件的动作,该可膨胀元件具有远端和近端,该可膨胀元件包括内部可膨胀元件和至少部分围绕内部可膨胀元件的多个外部可膨胀元件;输送可膨胀元件至治疗位点;使内部可膨胀元件在患者体内的通道中膨胀;使多个外部可膨胀元件在通道中膨胀;和允许血液经过在通道的内表面与内部和外部可膨胀元件之间形成的多个间隙。In another embodiment, a method of delivering an expandable member through the vasculature of a patient is provided. The method may include the act of providing an expandable member at the distal end of the elongated rod, the expandable member having a distal end and a proximal end, the expandable member comprising an inner expandable member and a plurality of outer expandable members at least partially surrounding the inner expandable member. An expandable member; delivering the expandable member to a treatment site; expanding an inner expandable member in a channel in a patient; expanding a plurality of outer expandable members in the channel; and allowing blood to pass between the inner surface of the channel and the inner and A plurality of gaps formed between the outer expandable elements.
在其他具体实施中,方法也可包括提供假体设备的动作,将假体设备布置在可膨胀元件上,和通过使内部和外部可膨胀元件膨胀的动作在通道内展开假体设备。In other implementations, the method can also include the acts of providing a prosthetic device, disposing the prosthetic device on the expandable member, and deploying the prosthetic device within the passageway by the acts of expanding the inner and outer expandable members.
在其他具体实施中,使内部可膨胀元件膨胀的动作可独立于使外部可膨胀元件膨胀的动作进行。在其他具体实施中,内部可膨胀元件可包括具有第一直径的第一内部球囊元件和具有第二直径的第二内部球囊元件。第一直径可小于第二直径并且第一和第二球囊元件可基本上是彼此同轴的。使内部可膨胀元件膨胀的动作可包括首先使第一内部球囊元件膨胀和接着使第二内部球囊元件膨胀。在其他具体实施中,使外部可膨胀元件膨胀的动作可包括使外部可膨胀元件的一个或多个膨胀,然后使其他的外部可膨胀元件膨胀。In other implementations, the act of expanding the inner expandable element can occur independently of the act of expanding the outer expandable element. In other implementations, the inner expandable member can include a first inner balloon member having a first diameter and a second inner balloon member having a second diameter. The first diameter may be smaller than the second diameter and the first and second balloon members may be substantially coaxial with each other. The act of expanding the inner expandable member may include first expanding the first inner balloon member and then expanding the second inner balloon member. In other implementations, the act of expanding the outer expandable elements may include expanding one or more of the outer expandable elements and then expanding the other outer expandable elements.
本发明前述的和其他的目标、特征和优势从参考附图进行的下面详细说明将变得更加明显。The foregoing and other objects, features and advantages of the present invention will become more apparent from the following detailed description made with reference to the accompanying drawings.
附图简述Brief description of the drawings
图1图解膨胀设备沿着远端部定位的输送系统。Figure 1 illustrates a delivery system with an expansion device positioned along a distal end.
图2A图解输送系统一部分的部分横截面视图,以膨胀构造显示膨胀设备。Figure 2A illustrates a partial cross-sectional view of a portion of the delivery system, showing the expansion device in an expanded configuration.
图2B图解图2A的输送系统的近视图。Figure 2B illustrates a close-up view of the delivery system of Figure 2A.
图3图解输送系统的膨胀设备的视图,以膨胀构造显示。Figure 3 illustrates a view of the expansion device of the delivery system, shown in an expanded configuration.
图4图解输送系统的膨胀设备的端视图,以在环中膨胀构造显示。Figure 4 illustrates an end view of the expansion device of the delivery system, shown in an expanded configuration in a loop.
图5A图解输送系统的膨胀设备的视图,以膨胀构造显示。Figure 5A illustrates a view of the expansion device of the delivery system, shown in an expanded configuration.
图5B图解沿着图5A的线5B-5B取的横截面视图。Figure 5B illustrates a cross-sectional view taken along line 5B-5B of Figure 5A.
图6图解输送系统的可选膨胀设备的横截面视图。Figure 6 illustrates a cross-sectional view of an optional expansion device of the delivery system.
图7图解膨胀设备的横截面视图,以收缩状态显示并且位于环中,假体设备安装在其上。Figure 7 illustrates a cross-sectional view of the expansion device, shown in the collapsed state and positioned in the annulus, with the prosthetic device mounted thereon.
图8图解图7的膨胀设备的横截面视图,以部分膨胀状态显示。Figure 8 illustrates a cross-sectional view of the expansion device of Figure 7, shown in a partially expanded state.
图9图解图7的膨胀设备的横截面视图,以充分膨胀的状态显示。Figure 9 illustrates a cross-sectional view of the expansion device of Figure 7, shown in a fully expanded state.
图10图解图7的膨胀设备的横截面视图,以膨胀状态显示,一些外部球囊元件缩小(deflate)。Figure 10 illustrates a cross-sectional view of the expansion device of Figure 7, shown in an expanded state, with some of the outer balloon elements deflated.
图11图解膨胀设备的横截面视图,以收缩状态显示并且位于环中,假体设备安装在其上。Figure 11 illustrates a cross-sectional view of an expansion device, shown in a collapsed state and positioned in an annulus with a prosthetic device mounted thereon.
图12图解图11的膨胀设备的横截面视图,以部分膨胀状态显示。Figure 12 illustrates a cross-sectional view of the expansion device of Figure 11, shown in a partially expanded state.
图13图解图11的膨胀设备的横截面视图,以充分膨胀状态显示。Figure 13 illustrates a cross-sectional view of the expansion device of Figure 11, shown in a fully expanded state.
图14图解膨胀设备的部分横截面视图,假体设备安装在其上。Figure 14 illustrates a partial cross-sectional view of an expansion device with a prosthetic device mounted thereon.
图15图解显示为膨胀状态的膨胀设备,在膨胀设备的远端和近端之间具有一个或多个血液灌注通道。Figure 15 diagrammatically shows the expansion device in an expanded state with one or more blood perfusion channels between the distal and proximal ends of the expansion device.
图16图解显示为膨胀状态的膨胀设备,在膨胀设备的远端和近端之间具有一个或多个血液灌注通道。Figure 16 diagrammatically shows the expansion device in an expanded state with one or more blood perfusion channels between the distal and proximal ends of the expansion device.
图17图解显示为膨胀状态的膨胀设备,在膨胀设备的远端和近端之间具有一个或多个血液灌注通道。Figure 17 diagrammatically shows the expansion device in an expanded state with one or more blood perfusion channels between the distal and proximal ends of the expansion device.
图18A图解膨胀设备的侧视图,具有内部球囊元件和多个分开的外部球囊元件,以收缩构造显示。Figure 18A illustrates a side view of an expansion device, with an inner balloon member and a plurality of separate outer balloon members, shown in a collapsed configuration.
图18B图解图18A的膨胀设备的侧视图,以膨胀构造显示。Figure 18B illustrates a side view of the expansion device of Figure 18A, shown in an expanded configuration.
图19A图解膨胀设备的侧视图,具有内部球囊元件和围绕内部球囊元件的外部球囊元件,以收缩构造显示。Figure 19A illustrates a side view of an expansion device with an inner balloon member and an outer balloon member surrounding the inner balloon member, shown in a collapsed configuration.
图19B图解图19A的膨胀设备的侧视图,以部分膨胀构造显示。Figure 19B illustrates a side view of the expansion device of Figure 19A, shown in a partially expanded configuration.
图19C图解图19A的膨胀设备的侧视图,以膨胀构造显示。Figure 19C illustrates a side view of the expansion device of Figure 19A, shown in an expanded configuration.
图20图解具有一个或多个灌注腔的输送系统的部分横截面视图。20 illustrates a partial cross-sectional view of a delivery system with one or more perfusion lumens.
图21图解图20的输送系统的部分横截面视图,以膨胀构造显示膨胀设备。21 illustrates a partial cross-sectional view of the delivery system of FIG. 20 showing the expansion device in an expanded configuration.
图22图解具有一个或多个灌注腔和可收缩部分的输送系统的部分横截面视图。22 illustrates a partial cross-sectional view of a delivery system having one or more perfusion lumens and a collapsible portion.
图23图解具有内部球囊元件和一个或多个灌注腔的膨胀设备的侧视图。Figure 23 illustrates a side view of an inflation device with an inner balloon member and one or more perfusion lumens.
图24图解具有内部球囊元件和一个或多个灌注腔的膨胀设备的侧视图。Figure 24 illustrates a side view of an expansion device with an inner balloon member and one or more perfusion lumens.
图25A图解具有一个或多个灌注腔的输送系统的部分横截面视图。25A illustrates a partial cross-sectional view of a delivery system with one or more perfusion lumens.
图25B图解图25A的输送系统沿着线25B-25B取的横截面视图。Figure 25B illustrates a cross-sectional view of the delivery system of Figure 25A taken along line 25B-25B.
图26A图解具有一个或多个灌注腔的输送系统的部分横截面视图。26A illustrates a partial cross-sectional view of a delivery system with one or more perfusion lumens.
图26B图解图26A的输送系统沿着线26B-26B取的横截面视图。Figure 26B illustrates a cross-sectional view of the delivery system of Figure 26A taken along line 26B-26B.
图27图解输送系统和将假体设备固定至该输送系统的远端的方法和装置。Figure 27 illustrates a delivery system and methods and apparatus for securing a prosthetic device to the distal end of the delivery system.
图28图解输送系统和将假体设备固定至该输送系统的远端的方法和装置。Figure 28 illustrates a delivery system and methods and apparatus for securing a prosthetic device to the distal end of the delivery system.
图29图解输送系统和将假体设备固定至该输送系统的远端的方法和装置。Figure 29 illustrates a delivery system and methods and apparatus for securing a prosthetic device to the distal end of the delivery system.
图30图解输送系统和将假体设备固定至该输送系统的远端的方法和装置。Figure 30 illustrates a delivery system and methods and apparatus for securing a prosthetic device to the distal end of the delivery system.
图31图解输送系统和将假体设备固定至该输送系统的远端的方法和装置。Figure 31 illustrates a delivery system and methods and apparatus for securing a prosthetic device to the distal end of the delivery system.
图32图解具有机械的内部膨胀设备和多个外部球囊元件的膨胀设备,以非膨胀(收缩)构造显示。Figure 32 illustrates an inflation device with a mechanical inner inflation device and a plurality of outer balloon elements, shown in a non-expanded (deflated) configuration.
图33图解具有机械的内部可膨胀元件和多个外部球囊元件的膨胀设备,以部分膨胀构造显示。Figure 33 illustrates an expansion device with a mechanical inner expandable element and a plurality of outer balloon elements, shown in a partially expanded configuration.
图34图解具有机械的内部可膨胀元件和多个外部球囊元件的膨胀设备,以膨胀构造显示。Figure 34 illustrates an expansion device having a mechanical inner expandable element and a plurality of outer balloon elements, shown in an expanded configuration.
图35图解图32的膨胀设备的实施方式,为了清楚外部球囊元件和大部分支柱被去除,以非膨胀(收缩)构造显示。Figure 35 illustrates the embodiment of the expansion device of Figure 32, shown in a non-expanded (deflated) configuration, with the outer balloon member and most of the struts removed for clarity.
图36图解图32的膨胀设备的实施方式,为了清楚外部球囊元件和大部分支柱被去除,以膨胀构造显示。Figure 36 illustrates the embodiment of the expansion device of Figure 32, shown in an expanded configuration, with the outer balloon member and most of the struts removed for clarity.
图37图解图32的膨胀设备的实施方式,为了清楚大部分外部球囊元件和支柱被去除,以膨胀构造显示。Figure 37 illustrates the embodiment of the expansion device of Figure 32, shown in an expanded configuration with most of the outer balloon elements and struts removed for clarity.
图38A图解输送收缩构造的假体设备至天然动脉瓣环中治疗位置的方法。38A illustrates a method of delivering a prosthetic device in a collapsed configuration to a treatment site in a native arterial valve annulus.
图38B图解使用图3的膨胀设备在天然动脉瓣环中展开图38A的假体设备的方法。38B illustrates a method of deploying the prosthetic device of FIG. 38A in a native arterial annulus using the expansion device of FIG. 3 .
图38C图解在天然动脉瓣环中展开状态的图38A的假体设备。Figure 38C illustrates the prosthetic device of Figure 38A in a deployed state in the native arterial valve annulus.
图39是钙化的天然动脉瓣环的示意图。Figure 39 is a schematic illustration of a calcified native arterial valve annulus.
图40图解安装在膨胀设备上的人工心脏瓣膜。Figure 40 illustrates a prosthetic heart valve mounted on an expansion device.
图41图解安装在膨胀设备上的人工心脏瓣膜的另一种实施方式。Figure 41 illustrates another embodiment of a prosthetic heart valve mounted on an expansion device.
图42图解多个外部球囊元件具有更短工作长度的膨胀设备的实施方式。Figure 42 illustrates an embodiment of an expansion device with multiple outer balloon elements having a shorter working length.
图43A是沿着图42的线43A-43A取的横截面视图。43A is a cross-sectional view taken along line 43A-43A of FIG. 42 .
图43B是沿着图42的线43B-43B取的横截面视图。43B is a cross-sectional view taken along line 43B-43B of FIG. 42 .
图44图解安装在在图42中显示的膨胀设备上的人工心脏瓣膜。FIG. 44 illustrates a prosthetic heart valve installed on the expansion device shown in FIG. 42 .
图45图解安装在膨胀设备上的人工心脏瓣膜的另一种实施方式。Figure 45 illustrates another embodiment of a prosthetic heart valve mounted on an expansion device.
图46图解膨胀设备的另一种实施方式,其中部分外部球囊元件附着至内部球囊元件的外表面。Figure 46 illustrates another embodiment of an expansion device in which a portion of the outer balloon member is attached to the outer surface of the inner balloon member.
图47A图解尾部连接和/或合并在一起的膨胀设备的另一种实施方式。Figure 47A illustrates another embodiment of an expansion device with tails connected and/or merged together.
图47B图解尾部合并在一起的膨胀设备的另一种实施方式。Figure 47B illustrates another embodiment of an expansion device with tails merged together.
图48A和48B图解尾部合并在一起的膨胀设备的另一种实施方式。48A and 48B illustrate another embodiment of an expansion device with tails merged together.
图49图解由单个球囊元件形成的膨胀设备的实施方式。Figure 49 illustrates an embodiment of an expansion device formed from a single balloon element.
图50A是沿着图49的线50A-50A取的横截面视图。FIG. 50A is a cross-sectional view taken along line 50A-50A of FIG. 49 .
图50B是沿着图49的线50B-50B取的横截面视图。FIG. 50B is a cross-sectional view taken along line 50B-50B of FIG. 49 .
发明详述Detailed description of the invention
下面的描述本质上是示例性的并且不打算以任何方式限制本发明的范围、适用性或构造。在不脱离本发明范围的情况下,可在本文所描述的元件的功能和布置方面可对所述的实施方式作出许多变化。The following description is exemplary in nature and is not intended to limit the scope, applicability, or configuration of the invention in any way. Many changes may be made to the described embodiments in the function and arrangement of elements described herein without departing from the scope of the invention.
如在本申请和权利要求中所使用,单数形式“一个”(“a”,“an”)和“所述(该,the)”包括复数形式,除非上下文明确地另外指出。另外地,术语“包括”意思是“包含”。进一步,术语“结合的”和“连接的”一般意思指电、电磁、和/或物理(例如,机械或化学)结合或连接,并且不排除在不存在具体相反语言的结合或连接的项目之间存在中间元件。As used in this application and the claims, the singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. Additionally, the term "comprises" means "comprises." Further, the terms "bonded" and "connected" generally mean electrical, electromagnetic, and/or physical (e.g., mechanical or chemical) bonding or connection, and are not excluded in the absence of specific opposite language bonding or connection items There are intermediate elements.
尽管为了便于表述,所公开方法的示例性实施方式的操作可以以具体、连续顺序描述,但是应当理解,公开的实施方式可包括不同于所公开的具体、连续顺序的操作顺序。例如,顺序描述的操作可在某些情况下重新安排或同时进行。进一步,结合一个具体实施方式提供的描述和公开内容不限于该实施方式,并且可应用于公开的任何实施方式。Although, for ease of presentation, the operations of exemplary embodiments of the disclosed methods may be described in a specific, sequential order, it should be understood that the disclosed embodiments may include orders of operations that differ from the specific, sequential order disclosed. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Further, descriptions and disclosures provided in connection with a particular embodiment are not limited to that embodiment, and may apply to any embodiment disclosed.
而且,为了简单,附图可能不显示公开的系统、方法和装置可结合其他系统、方法和装置使用的各种情形(基于该公开内容,本领域普通技术人员可容易理解)。另外地,说明书有时使用术语例如“产生”和“提供”以描述所公开的方法。这些术语是可被实施的实际操作的高水平抽象。对应于这些术语的实际操作可根据具体的实施而变化并且本领域普通技术人员基于本公开内容可容易理解。Moreover, for the sake of simplicity, the accompanying drawings may not show the various situations in which the disclosed systems, methods, and apparatuses may be used in conjunction with other systems, methods, and apparatuses as would be readily understood by one of ordinary skill in the art based on this disclosure. Additionally, the specification sometimes uses terms such as "produce" and "provide" to describe the disclosed methods. These terms are high-level abstractions of actual operations that can be implemented. The actual operations corresponding to these terms may vary depending on the specific implementation and can be readily understood by those of ordinary skill in the art based on this disclosure.
图1显示适合输送人工心脏瓣膜12(例如,人工动脉瓣)至心脏的输送装置10。装置10一般地包括易操纵的引导导管(guide catheter)14,和延伸通过引导导管14的球囊导管16。球囊导管16可包括多个腔以独立地输送流体至膨胀设备的一个或多个区域,如在下面更详细描述的。引导导管也可被称为柔性导管或主导管。如在图38A-38C中显示和在下面更详细描述的,人工瓣膜12可配置为在患者的主动脉环中展开。Figure 1 shows a delivery device 10 suitable for delivering a prosthetic heart valve 12 (eg, a prosthetic arterial valve) to the heart. Device 10 generally includes a steerable guide catheter 14 , and a balloon catheter 16 extending through guide catheter 14 . Balloon catheter 16 may include multiple lumens to independently deliver fluid to one or more regions of the inflation device, as described in more detail below. A guide catheter may also be called a flexible catheter or main catheter. As shown in FIGS. 38A-38C and described in more detail below, prosthetic valve 12 may be configured to deploy within the patient's aortic annulus.
引导导管14可包括柄部20和从柄部20延伸的伸长的导向管或杆22。球囊导管16可包括邻近柄部20的近端部24和伸长的杆26,其从近端部24延伸并通过柄部20和导向管22。柄部20可包括侧臂27,其具有与由柄部20限定的一个或多个腔流体连通的内部通道。膨胀设备28(例如,多个可膨胀球囊)可安装在球囊导管16的远端。在图1中,人工瓣膜12安装在膨胀设备28上并以蜷曲状态显示,提供减少直径的人工瓣膜12用于经患者的脉管系统输送至心脏。应当理解,膨胀设备28可配置为输送至没有人工心脏瓣膜安装在其上的治疗位置,为了不膨胀(off-expansion)设备输送人工瓣膜至治疗位置(如下面所讨论的)或为了在瓣膜成形术手术中使用膨胀设备。Guide catheter 14 may include a handle 20 and an elongate guide tube or stem 22 extending from handle 20 . Balloon catheter 16 may include a proximal end 24 adjacent handle 20 and an elongate shaft 26 extending from proximal end 24 and through handle 20 and guide tube 22 . The handle 20 may include a side arm 27 having an internal passageway in fluid communication with one or more lumens defined by the handle 20 . An inflation device 28 (eg, a plurality of inflatable balloons) may be mounted at the distal end of balloon catheter 16 . In FIG. 1 , prosthetic valve 12 is mounted on expansion device 28 and is shown in a crimped state, providing a reduced diameter prosthetic valve 12 for delivery to the heart through the patient's vasculature. It should be appreciated that the expansion device 28 may be configured for delivery to a treatment site without a prosthetic heart valve installed thereon, for off-expansion device delivery of a prosthetic valve to the treatment site (as discussed below) or for delivery of a prosthetic heart valve to the treatment site (as discussed below) or for delivery of a prosthetic heart valve to a treatment site after an annuloplasty Expansion devices are used during surgery.
虽然本文讨论的图解实施方式涉及蜷曲或安装在膨胀设备上的人工心脏瓣膜输送至治疗位置,但是应当理解,人工心脏瓣膜可以卷曲或安装在不同于膨胀设备位置的位置处(例如,膨胀设备的远侧或近侧)并可在使膨胀设备膨胀和展开人工瓣膜之前的某些时间在膨胀设备上重新定位。该不膨胀设备/闭合球囊(off-ballon)输送允许人工瓣膜被蜷曲成比如果人工瓣膜蜷曲在膨胀设备上可能的轮廓(profile)更低的轮廓。更低轮廓允许医师更容易地导航(navigate)输送装置(包括蜷曲的人工瓣膜)通过患者的脉管系统至治疗位置。当导航通过患者脉管系统的特别狭窄的部分,比如髂动脉时,更低轮廓的蜷曲人工瓣膜可尤其有用。While the illustrated embodiments discussed herein relate to delivery of a prosthetic heart valve crimped or mounted on an expansion device to a treatment site, it should be understood that a prosthetic heart valve may be crimped or mounted at a location other than that of the expansion device (e.g., the distal or proximal) and can be repositioned on the expansion device at some point before the expansion device is expanded and the prosthetic valve is deployed. This non-expandable device/off-ballon delivery allows the prosthetic valve to be crimped to a lower profile than would be possible if the prosthetic valve were crimped on an inflatable device. The lower profile allows the physician to more easily navigate the delivery device, including the crimped prosthetic valve, through the patient's vasculature to the treatment site. A lower profile crimped prosthetic valve may be especially useful when navigating through particularly narrow portions of a patient's vasculature, such as the iliac arteries.
喷嘴(nose piece)32可安装在输送装置10的远端以方便输送装置10前进通过患者的脉管系统至植入位点。在一些例子中,使喷嘴32连接至单独的伸长的杆可以是有用的,以便喷嘴32可独立于输送装置10的其他元件移动。A nose piece 32 may be mounted on the distal end of the delivery device 10 to facilitate advancement of the delivery device 10 through the patient's vasculature to the implantation site. In some instances, it may be useful to have the nozzle 32 attached to a separate elongate rod so that the nozzle 32 can move independently of the other elements of the delivery device 10 .
喷嘴32可由各种材料形成,包括各种塑料材料。可选地,喷嘴32可包括可膨胀球囊元件。当膨胀时,喷嘴32可一般形成锥形,如在图1中显示。当喷嘴32包括球囊元件时,喷嘴32的膨胀可通过使腔从输送装置的近端延伸至喷嘴32实现。流体加压设备可与腔流体接触,并且喷嘴32可通过流体加压设备膨胀和缩小。喷嘴32可被膨胀以帮助跟随喷嘴32通过患者的脉管系统和/或提供人工瓣膜12可邻接的表面,其可帮助保持人工瓣膜12在输送装置上的位置,直到在治疗位点展开。在下面更详细讨论的其他实施方式中,喷嘴32可具有一个或多个腔以提供血液灌注通过喷嘴32。Nozzle 32 may be formed from various materials, including various plastic materials. Optionally, nozzle 32 may comprise an inflatable balloon member. When expanded, the nozzle 32 may generally form a cone, as shown in FIG. 1 . When nozzle 32 comprises a balloon element, inflation of nozzle 32 may be accomplished by extending a lumen from the proximal end of the delivery device to nozzle 32 . A fluid pressurization device may be in fluid contact with the cavity, and the nozzle 32 may be expanded and deflated by the fluid pressurization device. The nozzle 32 can be inflated to help follow the nozzle 32 through the patient's vasculature and/or provide an abutable surface for the prosthetic valve 12 that can help maintain the position of the prosthetic valve 12 on the delivery device until deployed at the treatment site. In other embodiments discussed in more detail below, the nozzle 32 may have one or more lumens to provide perfusion of blood through the nozzle 32 .
如在图2A和2B中显示的,在图解的构造中,球囊导管16可进一步包括内部杆34(图2B),其从近端部24延伸并同轴延伸穿过外部杆26和膨胀设备28。膨胀设备28可支撑在内部杆34的远端部上,其从外部杆26向外延伸,膨胀设备的近端部36固定至外部杆26的远端(例如,使用合适的粘合剂)。设定内部杆34的外直径的大小以便沿着外部杆的整个长度在内部杆和外部杆之间限定环形空间。球囊导管的近端部24可用流体通道38形成,其可流体连接至用于使膨胀设备膨胀的流体源(例如,盐水源)。流体通道38与内部杆34和外部杆26之间的环形空间流体连通,以便来自流体源的流体可流动通过流体通道38、通过杆之间的空间,并进入膨胀设备28以使其膨胀并展开人工瓣膜12。As shown in FIGS. 2A and 2B , in the illustrated configuration, the balloon catheter 16 may further include an inner shaft 34 ( FIG. 2B ) extending from the proximal end 24 and extending coaxially through the outer shaft 26 and the inflation device. 28. The expansion device 28 may be supported on a distal portion of an inner rod 34 extending outwardly from the outer rod 26 to which a proximal end 36 of the expansion device is secured (eg, using a suitable adhesive). The outer diameter of the inner rod 34 is sized to define an annular space between the inner rod and the outer rod along the entire length of the outer rod. The proximal end 24 of the balloon catheter may be formed with a fluid channel 38, which may be fluidly connected to a source of fluid (eg, a source of saline) for inflating the expansion device. Fluid passage 38 is in fluid communication with the annular space between inner rod 34 and outer rod 26, so that fluid from a fluid source can flow through fluid passage 38, through the space between the rods, and into inflation device 28 to inflate and deploy it. Prosthetic valve 12.
近端部24也限定内部腔40,其与内部杆34的腔42连通。在图解的实施方式中,如果需要,可设定腔40、42的大小以接收鼻导管的杆。球囊导管16的内部杆34和外部杆26可由任何各种合适的材料形成,比如尼龙、编织的不锈钢丝或聚醚嵌段酰胺(商业上可得为)。杆26、34可具有由不同材料形成的纵向部分,以便沿着它们的长度改变杆的柔性。内部杆34可具有由形成的内部衬里或层以使与鼻导管杆的滑动摩擦力最小化。Proximal portion 24 also defines an interior lumen 40 that communicates with lumen 42 of inner stem 34 . In the illustrated embodiment, the cavities 40, 42 are sized to receive the stem of a nasal cannula, if desired. The inner shaft 34 and outer shaft 26 of the balloon catheter 16 may be formed from any of a variety of suitable materials, such as nylon, braided stainless steel wire, or polyether block amide (commercially available as ). The rods 26, 34 may have longitudinal portions formed from different materials in order to vary the flexibility of the rods along their length. The inner rod 34 may have a The inner lining or layer is formed to minimize sliding friction with the nasal cannula shaft.
膨胀设备28可包括多个球囊元件,包括,例如内部球囊元件50和多个外部球囊元件52,如在图2A和2B中显示的。如在图3和4中更清楚显示的,多个外部球囊元件52期望地至少部分围绕内部球囊元件50。外部球囊元件52可以以基本上相等的间隔围绕内部球囊元件50的外表面成角度地间隔开,如所显示的。The expansion device 28 may include a plurality of balloon elements, including, for example, an inner balloon element 50 and a plurality of outer balloon elements 52, as shown in Figures 2A and 2B. As shown more clearly in FIGS. 3 and 4 , a plurality of outer balloon members 52 desirably at least partially surround inner balloon member 50 . Outer balloon member 52 may be angularly spaced about the outer surface of inner balloon member 50 at substantially equal intervals, as shown.
每个外部球囊元件52也优选地沿着内部球囊元件50的外表面54轴向延伸。外部球囊元件52可包括主外表面53,其配置为接收和压迫(urgeagainst)人工瓣膜(即,使人工心脏瓣膜径向膨胀)和/或配置为压迫通道的内表面(即,在瓣膜成形术手术期间)。另外,每个外部球囊元件52可包括位于主外表面53的远端和/或近端的一个或多个狭窄的部分55。Each outer balloon member 52 also preferably extends axially along the outer surface 54 of the inner balloon member 50 . The outer balloon member 52 may include a major outer surface 53 configured to receive and urge against the prosthetic valve (i.e., to radially expand the prosthetic heart valve) and/or configured to compress the inner surface of the passageway (i.e., to urge against the prosthetic heart valve). during surgery). Additionally, each outer balloon member 52 may include one or more narrowed portions 55 located distally and/or proximally to major outer surface 53 .
如在图3中最佳可见,外部球囊元件52优选地固定在内部球囊元件50的近端56和远端58处。外部球囊元件52的近端和远端56、58可固定至内部球囊元件、外部杆26或近端56和远端58附近的其他结构。如果外部球囊元件52包括狭窄的部分55,则最靠近近端56和远端58的狭窄的部分55的部分可以是固定至内部球囊元件、外部杆或其他相关结构的外部球囊元件的部分。As best seen in FIG. 3 , outer balloon member 52 is preferably secured at proximal end 56 and distal end 58 of inner balloon member 50 . The proximal and distal ends 56 , 58 of the outer balloon member 52 may be secured to the inner balloon member, the outer shaft 26 , or other structures near the proximal and distal ends 56 , 58 . If the outer balloon member 52 includes a narrowed portion 55, the portion of the narrowed portion 55 closest to the proximal end 56 and the distal end 58 may be the outer balloon member fixed to the inner balloon member, outer rod, or other related structure. part.
外部球囊元件52也可在近端56或远端58中间的位置固定至内部球囊元件50的外表面54;但是,每个外部球囊元件52期望只固定在近端56和远端58,以便在近端56和远端58之间外部球囊元件52的部分可相对于内部球囊元件50的外表面54自由移动。通过不将外部球囊元件52固定至内部球囊元件50的外表面54,外部球囊元件52可沿着外表面54自由移动。该自由移动允许外部球囊元件52当压缩时实现更低的轮廓,因为它们能够自我排列和/或移动至膨胀设备28的压缩轮廓的间隙中。The outer balloon member 52 may also be secured to the outer surface 54 of the inner balloon member 50 at a position intermediate the proximal end 56 or the distal end 58; however, each outer balloon member 52 is desirably secured only at the proximal end 56 and the distal end 58 , so that the portion of the outer balloon member 52 between the proximal end 56 and the distal end 58 is free to move relative to the outer surface 54 of the inner balloon member 50 . By not securing outer balloon member 52 to outer surface 54 of inner balloon member 50 , outer balloon member 52 is free to move along outer surface 54 . This free movement allows the outer balloon elements 52 to achieve a lower profile when compressed, as they are able to align themselves and/or move into the gaps of the compressed profile of the expansion device 28 .
如在图4中显示的,当膨胀设备28在环61(或体内其他类似孔或通道)中扩张(膨胀)时,一个或多个间隙60优选地设置在至少两个邻近的外部球囊元件52之间。优选地,每个外部球囊元件52与邻近的外部球囊元件52间隔开,以便第一外部球囊元件52的侧(外)表面62不接触邻近外部球囊元件52的面对的侧表面62。因此,当膨胀设备28处于膨胀构造时,一个或多个间隙60可允许血液灌注通过在膨胀设备28的远端和近端56、58之间的体通道。As shown in FIG. 4, one or more gaps 60 are preferably provided between at least two adjacent outer balloon members when the inflation device 28 is expanded (inflated) in the annulus 61 (or other similar hole or passage in the body). Between 52. Preferably, each outer balloon member 52 is spaced apart from the adjacent outer balloon member 52 such that the side (outer) surface 62 of the first outer balloon member 52 does not contact the facing side surface of the adjacent outer balloon member 52. 62. Accordingly, the one or more gaps 60 may allow blood to perfuse through the body passage between the distal and proximal ends 56, 58 of the expansion device 28 when the expansion device 28 is in the expanded configuration.
应当理解,外部球囊元件52的数量和大小可变化。例如,如果最后期望的假体设备膨胀的内直径为约23mm,则膨胀设备的膨胀的直径可以以多种方式配置以实现该膨胀。例如,内部球囊元件50可具有约15mm的膨胀直径并且7个外部球囊元件(图4)每个可具有约4mm的膨胀直径。因此,膨胀设备的最终膨胀直径为约23mm——与膨胀假体设备期望的内直径相同的直径。在另一种实例中,内部球囊元件50可具有为约17mm的膨胀直径。如果假体设备应当被膨胀至约23mm(如在之前实例中所描述的),外部球囊元件52的膨胀直径应当比在之前实例中的小。在这种情况下,例如,外部球囊元件52的膨胀直径可为约3mm,以实现如在之前实例中相同的膨胀直径(即,23mm)。It should be understood that the number and size of outer balloon elements 52 may vary. For example, if the final desired expanded inner diameter of the prosthetic device is about 23 mm, the expanded diameter of the expanded device may be configured in various ways to achieve this expansion. For example, the inner balloon member 50 may have an inflated diameter of about 15 mm and the seven outer balloon members ( FIG. 4 ) may each have an inflated diameter of about 4 mm. Thus, the final expanded diameter of the expanded device is about 23 mm - the same diameter as the desired inner diameter of the expanded prosthetic device. In another example, inner balloon member 50 may have an expanded diameter of about 17 mm. If the prosthetic device should be expanded to about 23 mm (as described in the previous example), the expanded diameter of the outer balloon member 52 should be smaller than in the previous example. In this case, for example, the expanded diameter of the outer balloon member 52 may be about 3 mm to achieve the same expanded diameter as in the previous example (ie, 23 mm).
在一些实施方式中,有至少5个外部球囊元件。通过提供至少5个外部球囊元件,膨胀设备的外轮廓的横截面可近似圆形。更优选地,如在图4中显示的,有至少7个外部球囊元件,以为膨胀设备的外轮廓提供更圆的横截面轮廓。如在下面更详细描述的,当使用本文公开的膨胀设备使人工心脏瓣膜膨胀时,可尤其期望近似圆形横截面。In some embodiments, there are at least 5 outer balloon elements. By providing at least 5 outer balloon elements, the cross-section of the outer profile of the expansion device can be approximately circular. More preferably, as shown in Figure 4, there are at least 7 outer balloon elements to provide a more rounded cross-sectional profile to the outer profile of the expansion device. As described in more detail below, an approximately circular cross-section may be particularly desirable when expanding a prosthetic heart valve using the expansion devices disclosed herein.
图5A图解膨胀设备28的另一种实施方式,其包括内部球囊元件50和多个外部球囊元件52。图5B图解膨胀设备28的横截面视图,其显示该实施方式包括8个外部球囊元件52。如上面所讨论的,外部球囊元件52优选地不固定至膨胀设备28的近端56和远端58之间的内部球囊元件50。每个外部球囊元件52可在它各自的近端或远端分别固定至内部球囊元件的近端和远端。如果需要,外部球囊元件52可逐渐缩小至更小的直径(如在图5A中显示)或在近端56和远端58具有狭窄的部分(如在图3中显示)。FIG. 5A illustrates another embodiment of an expansion device 28 that includes an inner balloon member 50 and a plurality of outer balloon members 52 . FIG. 5B illustrates a cross-sectional view of the expansion device 28 showing that this embodiment includes eight outer balloon members 52 . As discussed above, the outer balloon member 52 is preferably not secured to the inner balloon member 50 between the proximal end 56 and the distal end 58 of the expansion device 28 . Each outer balloon member 52 may be secured at its respective proximal or distal end to the proximal and distal ends of the inner balloon member, respectively. If desired, outer balloon member 52 may taper to a smaller diameter (as shown in FIG. 5A ) or have narrowed portions at proximal end 56 and distal end 58 (as shown in FIG. 3 ).
参看图6,提供另一种实施方式的横截面视图。在图6中所显示的实施方式中,膨胀设备70包括多个内部球囊元件72和多个外部球囊元件74。球囊导管的杆76可在内部球囊元件72之间延伸经过膨胀设备。Referring to Figure 6, a cross-sectional view of another embodiment is provided. In the embodiment shown in FIG. 6 , the expansion device 70 includes a plurality of inner balloon elements 72 and a plurality of outer balloon elements 74 . The shaft 76 of the balloon catheter may extend between the inner balloon elements 72 past the inflation device.
多个内部球囊元件72可用于产生能够实现各种形状的球囊组件。例如,3个内部球囊元件72可用于产生横截面大体为三角(三叶,tri-lobular)的膨胀的形状(如在图6中显示)。例如,当使人工瓣膜在动脉瓣和/或主动脉根的部分中膨胀时,三角形状可以是有用的。可选地,可选择内部球囊元件和外部球囊元件,以便膨胀设备膨胀的形状的横截面是基本圆形的,如在上述实施方式中。当然,如果需要,在上述具有单个内部球囊元件的实施方式中,外部球囊元件的大小(即,膨胀直径)可被改变以形成非圆形形状的横截面(例如,三角、椭圆形)。Multiple inner balloon elements 72 may be used to create balloon assemblies capable of various shapes. For example, three inner balloon elements 72 may be used to create an inflated shape that is generally tri-lobular in cross-section (as shown in FIG. 6 ). For example, a triangular shape may be useful when expanding a prosthetic valve in portions of the aortic valve and/or aortic root. Optionally, the inner and outer balloon elements may be selected such that the expanded shape of the expansion device is substantially circular in cross-section, as in the embodiments described above. Of course, in the embodiments described above with a single inner balloon member, the size (i.e., inflated diameter) of the outer balloon member can be altered to form non-circular shaped cross-sections (e.g., triangular, elliptical) if desired. .
在本文的每个实施方式中,膨胀设备的球囊元件可同时膨胀(扩张)或它们可单独扩张(例如,顺序地或在一个或多个阶段中)。优选地,每个内部球囊元件与每个外部球囊元件流体分开或不同。类似地,每个外部球囊元件可与其他外部球囊元件流体分开或不同。通过单独使至少一些球囊元件膨胀,其中膨胀设备膨胀的通道可部分或完全闭塞较短的时间段。例如,图7-13图解膨胀设备各个膨胀阶段,其可配置为使假体设备,比如人工心脏瓣膜膨胀,或配置为进行瓣膜成形术手术。In each of the embodiments herein, the balloon elements of the expansion device may be inflated (expanded) simultaneously or they may be expanded separately (eg, sequentially or in one or more stages). Preferably, each inner balloon member is fluidly separate or distinct from each outer balloon member. Similarly, each outer balloon element may be fluidly separate or distinct from the other outer balloon elements. By individually inflating at least some of the balloon elements, the passageway in which the expansion device is inflated may be partially or completely occluded for a short period of time. For example, FIGS. 7-13 illustrate various stages of expansion of an expansion device, which may be configured to expand a prosthetic device, such as a prosthetic heart valve, or to perform a valvuloplasty procedure.
如在下面更详细描述的,在优选的实施方式中,外部球囊可以以交替组和/或顺序组膨胀,以增加膨胀设备的远端到膨胀设备的近端之间的血流(并且反之亦然)。因此,例如,如果提供两个顺序可膨胀(并且可缩小)组的外部球囊元件,第一组外部球囊元件可被膨胀并接着,在第一组膨胀之后,第二组外部球囊元件可被膨胀。在第二组被膨胀时,第一组可保持在它们的膨胀构造。通过以该方式使外部球囊元件顺序地膨胀,可减少两组外部球囊元件被扩张的时间量,其是有益的,因为当所有外部球囊元件被膨胀时,膨胀设备的末端之间的灌注路径被减少。类似地,两组外部球囊元件可被顺序缩小以在该过程期间增加血液灌注路径并减少灌注路径被减少的时间量。虽然该方法仅以两组外部球囊元件进行描述,但是应当理解,可提供超过两组可顺序膨胀和/或可交替膨胀的球囊元件。As described in more detail below, in preferred embodiments, the external balloons can be inflated in alternating and/or sequential groups to increase blood flow between the distal end of the inflatable device to the proximal end of the inflatable device (and vice versa). as well). Thus, for example, if two sequentially inflatable (and deflatable) sets of outer balloon elements are provided, a first set of outer balloon elements can be inflated and then, after the first set is inflated, a second set of outer balloon elements can be expanded. Can be inflated. The first sets may remain in their expanded configuration while the second set is expanded. By inflating the outer balloon members sequentially in this manner, the amount of time that the two sets of outer balloon members are inflated can be reduced, which is beneficial because when all the outer balloon members are inflated, the distance between the ends of the expansion device is reduced. The perfusion path is reduced. Similarly, the two sets of outer balloon elements may be deflated sequentially to increase the blood perfusion path and reduce the amount of time that the perfusion path is reduced during the procedure. Although the method is described with only two sets of outer balloon elements, it should be understood that more than two sets of sequentially inflatable and/or alternately inflatable balloon elements may be provided.
另外,如本文更详细描述的,元件的顺序和/或交替膨胀不限于外部球囊元件。在各种实施方式中,内部和外部元件(球囊或机械的)可被顺序地膨胀和/或收缩。例如,第一内部球囊可被膨胀并接着一个或多个外部球囊可被膨胀。可选地,外部元件(一个或多个)可被膨胀并接着内部元件可被膨胀。Additionally, as described in more detail herein, the sequential and/or alternate inflation of elements is not limited to outer balloon elements. In various embodiments, the inner and outer elements (balloon or mechanical) can be expanded and/or deflated sequentially. For example, a first inner balloon may be inflated and then one or more outer balloons may be inflated. Alternatively, the outer element(s) may be expanded and then the inner element may be expanded.
参看图7,假体设备86蜷曲于其上的膨胀设备以收缩构造显示。膨胀设备包括以缩小构造并支撑在内部杆81上的内部球囊元件82和多个外部球囊元件84。显示7个外部球囊元件84,但是如上面所讨论,在一些实施方式中,外部球囊元件的数量可以更少或更多。假体设备86蜷曲在收缩的膨胀设备上。如上面所讨论的,每个外部球囊元件84优选地具有相对于球囊元件82自由地浮动或可移动的部分(例如,中心纵向部分或轴向部分),这允许外部球囊元件84收缩至更低的轮廓形状。为了展开(膨胀)假体设备86,膨胀设备和假体设备86可被移动至假体设备将被膨胀的治疗位点(例如,体通道或孔)。治疗位点可以是,例如天然瓣膜环80,如在图7-8中显示的。如在图7中可见,当人工瓣膜位于其上的膨胀设备完全收缩时,血液可经过在蜷曲假体设备86的外表面和环80的内表面之间的空间中的环。Referring to Figure 7, the expanded device with the prosthetic device 86 crouched thereon is shown in a collapsed configuration. The expansion device includes an inner balloon member 82 and a plurality of outer balloon members 84 in a deflated configuration and supported on an inner rod 81 . Seven outer balloon elements 84 are shown, but as discussed above, in some embodiments the number of outer balloon elements may be fewer or greater. The prosthetic device 86 is crimped over the contracted expansion device. As discussed above, each outer balloon member 84 preferably has a freely floating or movable portion (e.g., a central longitudinal or axial portion) relative to the balloon member 82, which allows the outer balloon member 84 to deflate. to lower profile shapes. To deploy (expand) the prosthetic device 86, the expansion device and the prosthetic device 86 may be moved to the treatment site (eg, a body passage or hole) where the prosthetic device is to be expanded. The treatment site may be, for example, the native valve annulus 80, as shown in Figures 7-8. As can be seen in FIG. 7 , blood can pass through the annulus in the space between the outer surface of the crimped prosthetic device 86 and the inner surface of the annulus 80 when the expansion device on which the prosthetic valve rests is fully deflated.
参看图8,第一阶段的展开可包括通过使内部球囊元件82膨胀至它的膨胀构造使膨胀设备部分膨胀。内部球囊元件82的膨胀造成假体设备86部分膨胀,如在图8中显示的。因此,内部球囊元件82可被膨胀,而外部球囊元件84保持处于它们的收缩构造。为了促进内部球囊元件和外部球囊元件独立的和/或分开的膨胀,可提供分开的腔。在一些实施方式中,分开的腔可为并排构造;但是,应当理解,其他构造是可能的。Referring to Figure 8, the first stage of deployment may include partially inflating the expansion device by inflating the inner balloon member 82 to its expanded configuration. Inflation of the inner balloon member 82 causes partial expansion of the prosthetic device 86 as shown in FIG. 8 . Thus, the inner balloon member 82 can be expanded while the outer balloon members 84 remain in their collapsed configuration. To facilitate independent and/or separate inflation of the inner and outer balloon elements, separate lumens may be provided. In some embodiments, the separate chambers may be in a side-by-side configuration; however, it should be understood that other configurations are possible.
内部球囊元件82优选地膨胀至足够保持对假体设备86的摩擦力的大小。如果需要,假体设备86可通过移动膨胀设备根据需要重新定位(例如,通过在近端或远端方向上移动内部杆81)。对假体设备86的摩擦力可帮助保持假体设备86在膨胀设备上的位置。The inner balloon member 82 is preferably inflated to a size sufficient to maintain friction against the prosthetic device 86 . If desired, the prosthetic device 86 can be repositioned as desired by moving the expansion device (eg, by moving the inner rod 81 in a proximal or distal direction). Friction against the prosthetic device 86 may help maintain the position of the prosthetic device 86 over the expansion device.
如在图8中显示的,因为部分膨胀的膨胀设备和假体设备86的外直径小于环的内直径,所以血液仍然能够经过在部分膨胀的假体设备86的外表面和环80的内表面之间的空间中的环。As shown in FIG. 8, because the outer diameter of the partially expanded expansion device and prosthetic device 86 is smaller than the inner diameter of the ring, blood can still pass through the outer surface of the partially expanded prosthetic device 86 and the inner surface of the ring 80. rings in the space between.
参看图9,膨胀设备以进一步膨胀的构造(例如,充分膨胀的构造)显示,内部球囊元件82处于膨胀状态并且外部球囊元件84处于膨胀状态。膨胀设备的充分膨胀也使假体设备86膨胀至它的充分展开的状态。如在图9中可见的,并且如上面就图4所讨论的,间隙60存在于内部球囊元件82和外部球囊元件84之间以及环80和内部球囊元件82之间。当膨胀设备在充分膨胀的情况下,这些间隙允许血液在假体设备86的近端和远端之间通过。Referring to Figure 9, the expansion device is shown in a further expanded configuration (eg, a fully inflated configuration) with the inner balloon member 82 in an inflated state and the outer balloon member 84 in an inflated state. Sufficient expansion of the expansion device also expands the prosthetic device 86 to its fully deployed state. As can be seen in FIG. 9 , and as discussed above with respect to FIG. 4 , gaps 60 exist between inner balloon member 82 and outer balloon member 84 and between ring 80 and inner balloon member 82 . These gaps allow blood to pass between the proximal and distal ends of the prosthetic device 86 when the expansion device is fully inflated.
因此,如在图7-9中显示的,膨胀设备可使假体设备膨胀同时允许血液灌注膨胀设备的近端和远端之间。而且,膨胀设备在假体设备的展开期间(或在瓣膜成形术手术期间)分阶段地膨胀以使血流最大化。而且,因为当假体设备处于部分膨胀的构造时内部球囊元件82可被充分膨胀,部分膨胀的膨胀设备的大小和形状是可预测的。相反,在输送设备的膨胀期间尽管常规的球囊元件可被部分膨胀,但是常规的球囊元件的形状在膨胀期间一般是不可预测的,这是因为球囊元件不倾向于符合预测的形状直到实现球囊元件的充分膨胀。Thus, as shown in Figures 7-9, the expansion device can expand the prosthetic device while allowing blood to perfuse between the proximal and distal ends of the expansion device. Also, the expansion device expands in stages during deployment of the prosthetic device (or during a valvuloplasty procedure) to maximize blood flow. Also, because the inner balloon member 82 can be fully inflated when the prosthetic device is in the partially expanded configuration, the size and shape of the partially expanded expansion device is predictable. In contrast, while conventional balloon elements may be partially inflated during inflation of a delivery device, the shape of conventional balloon elements is generally unpredictable during inflation because the balloon element does not tend to conform to the predicted shape until Sufficient inflation of the balloon element is achieved.
在一些实施方式中,在内部球囊元件82被膨胀之前外部球囊元件84可被膨胀。优选地,当首先使外部球囊元件84膨胀时,外部球囊元件84可共同地膨胀至足够保持对假体设备86的摩擦力的大小,以实现同样的重新定位性,如上面就内部球囊元件82首先被膨胀的实施方式所描述的。In some embodiments, the outer balloon member 84 can be inflated before the inner balloon member 82 is inflated. Preferably, when the outer balloon member 84 is inflated first, the outer balloon members 84 are collectively inflatable to a magnitude sufficient to maintain friction against the prosthetic device 86 to achieve the same repositionability as with the inner ball above. The embodiment in which the balloon member 82 is first inflated is described.
在另一种实施方式中,外部球囊元件84可相对于彼此分开膨胀。因此,如在图10中显示的,内部球囊元件82可被膨胀以部分膨胀假体设备86,并且接着外部球囊元件84可被分阶段地膨胀。例如,如在图10中显示,交替的外部球囊元件84以膨胀状态显示。以这种方式,在内部球囊元件82和环80之间存在的间隙60比图9中上述的那些间隙大,并且更多的血液灌注可能通过间隙60。In another embodiment, the outer balloon members 84 are separately inflatable relative to each other. Thus, as shown in FIG. 10, the inner balloon member 82 may be inflated to partially expand the prosthetic device 86, and then the outer balloon member 84 may be expanded in stages. For example, as shown in FIG. 10, alternating outer balloon members 84 are shown in an inflated state. In this way, the gap 60 that exists between the inner balloon member 82 and the ring 80 is larger than those gaps described above in FIG. 9 , and more blood perfusion is possible through the gap 60 .
10中显示的构造可以是假体设备86展开阶段的说明或者它可以是在假体设备86展开之后膨胀设备收缩的说明。即,图10中显示的缩小的外部球囊元件84可以为处于中间阶段并且随后被扩张以帮助假体设备86的膨胀。可选地,图10中显示的构造可以是在假体设备86被充分展开之后一个或多个外部球囊元件84选择性收缩(缩小)的说明。因此,膨胀设备可迅速减少它的轮廓以允许血液灌注增加,然后被完全缩小或收缩。The configuration shown in 10 may be an illustration of the stage of deployment of the prosthetic device 86 or it may be an illustration of the contraction of the expansion device after the deployment of the prosthetic device 86 . That is, the deflated outer balloon member 84 shown in FIG. 10 may be in an intermediate stage and then expanded to assist in expansion of the prosthetic device 86 . Alternatively, the configuration shown in FIG. 10 may be an illustration of the selective deflation (deflation) of one or more outer balloon members 84 after the prosthetic device 86 has been fully deployed. Thus, an expanding device can rapidly reduce its profile to allow increased blood perfusion, and then be fully deflated or contracted.
膨胀设备膨胀(例如,使假体设备膨胀或进行瓣膜成形术)之后,膨胀设备也可被分阶段地缩小或收缩。例如,在内部球囊(一个或多个)缩小之前,外部球囊可被缩小。以这种方式,血液可被允许在邻近缩小的球囊元件的区域中膨胀设备的近端和远端之间通过并且可减轻对使剩余膨胀的球囊元件缩小的急迫性。Following expansion of the expansion device (eg, to expand a prosthetic device or perform valvuloplasty), the expansion device may also be deflated or deflated in stages. For example, the outer balloon(s) may be deflated before the inner balloon(s) are deflated. In this way, blood may be allowed to pass between the proximal and distal ends of the inflation device in the region adjacent to the deflated balloon member and the urgency to deflate the remaining inflated balloon member may be alleviated.
在另一种实施方式中,膨胀设备可包括多直径内部球囊组件,所述球囊组件由多个同轴布置的内部球囊元件组成,这样配置使得内部球囊元件可被膨胀至不同的直径。例如,图11图解假体设备102(例如,人工瓣膜)蜷曲在其上的膨胀设备100。膨胀设备100可包括第一内部球囊元件104和第二内部球囊元件106。第一内部球囊元件104和第二内部球囊元件106优选地是同轴的。在图解的实施方式中,第一内部球囊元件104和第二球囊元件106可都被支撑在内部杆107上。以与上述类似的方式,多个外部球囊元件108可至少部分围绕第一内部球囊元件104和第二内部球囊元件106。In another embodiment, the inflation device may comprise a multi-diameter inner balloon assembly consisting of a plurality of coaxially arranged inner balloon elements configured such that the inner balloon elements can be inflated to different diameter. For example, FIG. 11 illustrates an expansion device 100 with a prosthetic device 102 (eg, a prosthetic valve) crimped thereon. The expansion device 100 may include a first inner balloon member 104 and a second inner balloon member 106 . The first inner balloon member 104 and the second inner balloon member 106 are preferably coaxial. In the illustrated embodiment, first inner balloon member 104 and second balloon member 106 may both be supported on inner rod 107 . In a manner similar to that described above, a plurality of outer balloon members 108 may at least partially surround first inner balloon member 104 and second inner balloon member 106 .
第一内部球囊元件104和第二内部球囊元件106优选地具有不同的直径,以便膨胀设备100可扩张至多个可预测的、增加的直径。例如,第一内部球囊元件104可比第二内部球囊元件106具有更小的扩张直径。因此,如在图12中显示,当膨胀设备100被扩张(膨胀)至第一构造时——其中第一内部球囊元件104被充分扩张并且外部球囊元件108被充分扩张,膨胀设备的总扩张直径(轮廓)小于环110的内直径。但是,如在图13中显示的,当膨胀设备100被扩张(膨胀)至第二构造时——其中第二内部球囊元件106被充分扩张并且外部球囊元件108被充分扩张时,膨胀设备的总扩张直径(轮廓)基本上与环110的内直径相同。The first inner balloon member 104 and the second inner balloon member 106 preferably have different diameters so that the expansion device 100 is expandable to a plurality of predictable, increasing diameters. For example, first inner balloon member 104 may have a smaller expanded diameter than second inner balloon member 106 . Thus, as shown in FIG. 12, when the expansion device 100 is inflated (inflated) to a first configuration - in which the first inner balloon member 104 is fully expanded and the outer balloon member 108 is fully expanded, the overall size of the expansion device The expanded diameter (profile) is smaller than the inner diameter of the ring 110 . However, as shown in FIG. 13, when the expansion device 100 is expanded (inflated) to the second configuration - wherein the second inner balloon member 106 is fully expanded and the outer balloon member 108 is fully expanded, the expansion device The overall expanded diameter (profile) of the ring 110 is substantially the same as the inner diameter of the ring 110.
因此,膨胀设备可分阶段地扩张(膨胀),特征为可预测的、增加的直径。即,膨胀设备的膨胀可包括在缩小阶段(图11)和充分膨胀阶段(图13)之间的中间阶段(图12)。如在图12中显示的,在该中间阶段中,膨胀设备100仅部分被膨胀并且血液可更容易在膨胀设备100的近端和远端之间通过。优选地,第一和第二内部球囊元件是同心并且同轴的,以便它们可相对于假体设备以可预测的和均匀的方式膨胀。另外,如在其他实施方式中,应当理解,即使在充分膨胀的阶段(图13),通过经过在邻近的外部球囊元件108之间存在的间隙(空间)109,血液能够在膨胀设备100的近端和远端之间通过。Thus, the expansion device can be expanded (inflated) in stages, characterized by predictable, increasing diameters. That is, the expansion of the expansion device may include an intermediate stage (Fig. 12) between the deflated stage (Fig. 11) and the fully expanded stage (Fig. 13). As shown in FIG. 12 , in this intermediate stage the inflation device 100 is only partially inflated and blood can more easily pass between the proximal and distal ends of the inflation device 100 . Preferably, the first and second inner balloon members are concentric and coaxial so that they expand in a predictable and uniform manner relative to the prosthetic device. In addition, as in other embodiments, it should be understood that even at the fully inflated stage ( FIG. 13 ), blood can flow through the gap (space) 109 that exists between adjacent outer balloon elements 108 , even in the fully inflated stage ( FIG. 13 ). pass between the proximal and distal ends.
如上所述的,在一个或多个外部元件之前内部元件可被扩张,或在内部元件之前一个或多个外部元件可被扩张。通过首先使外部元件扩张,可在膨胀过程的早期在邻近的外部球囊元件之间形成间隙(例如,通道)。当内部元件被膨胀时,邻近的外部球囊之间的这些间隙可被保持。以这种方式,随着膨胀设备从部分膨胀状态移动至充分膨胀状态,在膨胀设备中存在间隙,并且使得血液可在整个膨胀过程期间流过该设备。As described above, the inner element may be expanded before one or more outer elements, or one or more outer elements may be expanded before the inner element. By expanding the outer elements first, gaps (eg, channels) can be formed between adjacent outer balloon elements early in the inflation process. These gaps between adjacent outer balloons may be maintained when the inner element is inflated. In this way, as the inflation device moves from a partially inflated state to a fully inflated state, gaps exist in the inflation device and allow blood to flow through the device during the entire inflation process.
在另一种实施方式中,膨胀设备可包括内部球囊元件127和至少部分围绕内部球囊元件127的多个外部球囊元件128。外部球囊元件128可相对于假体设备120定位以增加假体设备120的远端和近端之间的灌注。例如,如在图14中显示的,假体设备120可包括框架元件122和连接至框架元件122的多个小叶124。邻近的小叶124形成多个连合126。如在图14中显示的,假体设备120可安装在膨胀设备上,以便外部球囊元件128不与连合126对齐(或与其间隔开)。通过定位外部球囊元件128,使得它们不位于连合126的区域,通过利用血液流动经过假体设备120本身,可实现假体设备120的近端和远端之间的最大血液灌注。In another embodiment, the expansion device may include an inner balloon member 127 and a plurality of outer balloon members 128 at least partially surrounding the inner balloon member 127 . Outer balloon member 128 may be positioned relative to prosthetic device 120 to increase perfusion between the distal and proximal ends of prosthetic device 120 . For example, as shown in FIG. 14 , a prosthetic device 120 may include a frame member 122 and a plurality of leaflets 124 connected to the frame member 122 . Adjacent leaflets 124 form a plurality of commissures 126 . As shown in FIG. 14 , the prosthetic device 120 may be mounted on the expansion device such that the outer balloon member 128 is not aligned with (or spaced from) the commissures 126 . By positioning the outer balloon elements 128 so that they are not located in the area of the commissures 126, maximum blood perfusion between the proximal and distal ends of the prosthetic device 120 can be achieved by utilizing blood flow through the prosthetic device 120 itself.
虽然上述球囊元件可以各种横截面形状(例如圆形、三角、椭圆形等)形成,但优选地它们的横截面是基本上圆形的。当经历高压扩张时——如对于使假体设备膨胀所需要的,无论它们预先设定的形状如何,球囊元件有“圆化(round out)”的趋势。例如,虽然可能热定型球囊以具有椭圆形横截面,但是在高压扩张期间该椭圆形形状将倾向于扩张至基本上圆的横截面形状。因此,上述实施方式的优势是每个球囊元件(例如,内部和外部球囊元件)的横截面可配置为圆形,而膨胀设备横截面的总体轮廓更复杂并包括用于血液灌注的间隙。因此,即使经历高压膨胀时,膨胀设备最终的形状基本上与它的预先设定的形状相同,这是因为每个球囊具有预先设定的、具有基本上圆形横截面轮廓的形状。相反,具有非圆形横截面轮廓的球囊元件当高压膨胀时可能变形,并且球囊元件的最终形状可能不是所期望的。While the balloon elements described above may be formed in various cross-sectional shapes (eg, circular, triangular, oval, etc.), preferably they are substantially circular in cross-section. Balloon elements have a tendency to "round out" when subjected to high pressure expansion, as required for inflating a prosthetic device, regardless of their pre-set shape. For example, while it is possible to heat set a balloon to have an oval cross-section, this oval shape will tend to expand to a substantially round cross-sectional shape during high pressure inflation. Thus, an advantage of the embodiments described above is that the cross-section of each balloon element (e.g., inner and outer balloon elements) can be configured to be circular, while the overall profile of the cross-section of the inflation device is more complex and includes gaps for blood perfusion. . Thus, even when undergoing high pressure inflation, the final shape of the expansion device is substantially the same as its predetermined shape, since each balloon has a predetermined shape having a substantially circular cross-sectional profile. Conversely, a balloon member having a non-circular cross-sectional profile may deform when inflated at high pressure, and the final shape of the balloon member may not be as desired.
在另一种实施方式中,提供了其他膨胀设备,其当经历高压膨胀时防止球囊元件的变形和/或使球囊元件的变形最小化。参看图15,公开了具有多个突出部分的膨胀设备150。膨胀设备150包括主体152和多个突出部分154,其从主体152径向延伸并且绕主体圆周地延伸。突出部分154限定沿着膨胀设备150的凹槽156,以允许血液从膨胀设备的近端158经过到达远端160。突出部分154优选地限定纵向凹槽162和圆周凹槽164。纵向凹槽162在基本上纵向方向上在近端158和远端160之间延伸,而圆周凹槽164在围绕膨胀设备150的圆周方向上延伸。优选地,纵向凹槽162基本上延伸膨胀设备150的长度并且圆周凹槽164基本上围绕主体152的圆周延伸;但是,只要当膨胀设备150在身体的孔或通道中处于膨胀构造时,纵向凹槽162和圆周凹槽164在膨胀设备150的近端158和远端160之间共同地形成一个或多个通道,则膨胀设备150可有效地允许血液在两个末端158、160之间通过。In another embodiment, other inflation devices are provided that prevent and/or minimize deformation of the balloon member when subjected to high pressure inflation. Referring to Figure 15, an expansion device 150 having a plurality of protrusions is disclosed. The expansion device 150 includes a main body 152 and a plurality of protrusions 154 extending radially from the main body 152 and extending circumferentially around the main body. Protruding portion 154 defines a groove 156 along inflation device 150 to allow passage of blood from proximal end 158 to distal end 160 of the inflation device. Protruding portion 154 preferably defines a longitudinal groove 162 and a circumferential groove 164 . The longitudinal groove 162 extends in a substantially longitudinal direction between the proximal end 158 and the distal end 160 , while the circumferential groove 164 extends in a circumferential direction around the expansion device 150 . Preferably, the longitudinal groove 162 extends substantially the length of the expansion device 150 and the circumferential groove 164 extends substantially around the circumference of the body 152; Grooves 162 and circumferential grooves 164 collectively form one or more channels between proximal end 158 and distal end 160 of expansion device 150 , and expansion device 150 is effective to allow passage of blood between the two ends 158 , 160 .
如上所叙述,当经历高压时,球囊元件具有朝着圆形横截面构造变形的趋势。圆周凹槽164起到使扩张压的有害影响最小化的作用。具体而言,因为圆周凹槽164优选地围绕膨胀设备150的圆周延伸,所以在那些位置处当扩张时膨胀设备150可实现圆形的横截面,以使得在沿着球囊元件长度的其他位置处膨胀设备150的变形最小化。换句话说,通过使得在凹槽处的膨胀设备150部分实现圆形的横截面,在沿着膨胀设备150的纵向轴的其他位置处的变形力被阻止或至少被最小化。As stated above, when subjected to high pressures, balloon elements have a tendency to deform towards a circular cross-sectional configuration. The circumferential groove 164 serves to minimize the detrimental effects of distension pressure. Specifically, because the circumferential grooves 164 preferably extend around the circumference of the inflation device 150, the inflation device 150 can achieve a circular cross-section when expanded at those locations such that at other locations along the length of the balloon member Deformation of the expansion device 150 is minimized. In other words, by making the part of the expansion device 150 at the groove a circular cross-section, deformation forces at other locations along the longitudinal axis of the expansion device 150 are prevented or at least minimized.
因此,膨胀设备150可具有沿着膨胀设备150的长度延伸的多个圆形横截面区域。尤其地,这种圆形横截面区域可处于一个或多个圆周凹槽的位置处。另外,因为膨胀设备具有突出部分和在突出部分之间形成的凹槽,所以膨胀设备期望地沿着膨胀设备150的长度具有多个不同的横截面形状/大小。例如,在圆周凹槽处的横截面可以是圆形的并且具有一定的大小(直径),而在其他位置处的横截面可以是非圆形的并且大小比圆周凹槽的横截面更大。Accordingly, the expansion device 150 may have a plurality of circular cross-sectional areas extending along the length of the expansion device 150 . In particular, such a circular cross-sectional area may be at the location of one or more circumferential grooves. Additionally, because the expansion device has protrusions and grooves formed between the protrusions, the expansion device desirably has a number of different cross-sectional shapes/sizes along the length of the expansion device 150 . For example, the cross-section at the circumferential groove may be circular and have a certain size (diameter), while the cross-section at other locations may be non-circular and larger than the cross-section of the circumferential groove.
图16图解膨胀设备150的另一种实施方式。图16的膨胀设备比图15的膨胀设备包括更少的突出部分154。另外,图16的突出部分154沿着圆周方向是圆形的或锥形的。这些圆形部分166可降低非圆形部分“爆裂(blow-out)”的可能性。如在图15中,纵向凹槽162在近端158和远端160之间基本上纵向方向上延伸,而圆周凹槽164在围绕膨胀设备150的圆周方向上延伸。FIG. 16 illustrates another embodiment of an expansion device 150 . The expansion device of FIG. 16 includes fewer protrusions 154 than the expansion device of FIG. 15 . In addition, the protruding portion 154 of FIG. 16 is circular or tapered in the circumferential direction. These circular portions 166 reduce the likelihood of "blow-out" of non-circular portions. As in FIG. 15 , the longitudinal groove 162 extends in a substantially longitudinal direction between the proximal end 158 and the distal end 160 , while the circumferential groove 164 extends in a circumferential direction around the expansion device 150 .
虽然显示在图15和16中的每个膨胀设备150具有以格子样方式均匀分布的突出部分,但是,应当理解,突出部分可以沿着膨胀设备150的主体非均匀地间隔开。While each expansion device 150 is shown in FIGS. 15 and 16 as having protrusions evenly distributed in a grid-like fashion, it should be understood that the protrusions may be non-uniformly spaced along the body of the expansion device 150 .
在另一种实施方式中,提供膨胀设备170。如在图17中显示的,膨胀设备170包括内部球囊元件172和外部球囊元件(或突出部分)174,其从膨胀设备170的近端176延伸至远端178。通过绕内部球囊元件172的主体缠绕一圈或多圈,外部球囊元件174从近端176延伸至远端178。优选地,外部球囊元件174绕内部球囊元件172以图17显示的基本上螺旋的方式缠绕。因此,当内部球囊元件172和外部球囊元件174被膨胀时,血液可通过在外部球囊元件174的邻近径向突出部分之间形成的通道180灌注在近端176和远端178之间。如果外部球囊元件174围绕内部球囊元件172的表面以基本上螺旋的构造延伸,则所得通道的形状将也是基本上螺旋的。In another embodiment, an expansion device 170 is provided. As shown in FIG. 17 , expansion device 170 includes an inner balloon member 172 and an outer balloon member (or protrusion) 174 that extends from a proximal end 176 to a distal end 178 of expansion device 170 . Outer balloon member 174 extends from proximal end 176 to distal end 178 by wrapping one or more turns around the body of inner balloon member 172 . Preferably, the outer balloon member 174 is wrapped around the inner balloon member 172 in a substantially helical manner as shown in FIG. 17 . Thus, when inner balloon member 172 and outer balloon member 174 are inflated, blood can perfuse between proximal end 176 and distal end 178 through channel 180 formed between adjacent radially projecting portions of outer balloon member 174. . If the outer balloon member 174 extends in a substantially helical configuration around the surface of the inner balloon member 172, the shape of the resulting channel will also be substantially helical.
外部球囊元件174优选地与内部球囊元件172连接以便当外部球囊元件174被膨胀时保持螺旋的形状。但是,可优选地使部分外部球囊元件自由(未附着至内部球囊元件172),以便当球囊元件被缩小时膨胀设备170可具有更小的减小的轮廓。换句话说,如上面就显示在图3中的实施方式所描述的,外部球囊元件174可通过移动进入在膨胀设备170的压缩轮廓中的间隙自我排列。Outer balloon member 174 is preferably connected to inner balloon member 172 so as to maintain the helical shape when outer balloon member 174 is inflated. However, it may be preferable to leave a portion of the outer balloon member free (not attached to the inner balloon member 172) so that the expansion device 170 may have a smaller reduced profile when the balloon member is deflated. In other words, the outer balloon member 174 can align itself by moving into a gap in the compressed profile of the expansion device 170 as described above with respect to the embodiment shown in FIG. 3 .
如上面所讨论,球囊元件优选地具有圆形的横截面以防止或减小当扩张时球囊元件变形的机会。但是,其他形状可能是有优势的。例如,图18A和18B图解与显示在图3和4中的膨胀设备相似的膨胀设备190,除了内部球囊元件192是花生形的或狗骨形的。即,内部球囊元件192在近端194和远端196附近的部分比在中心的部分具有更宽的半径。多个外部球囊元件198基本上延伸内部球囊元件192的长度。外部球囊元件可以与其他实施方式的外部球囊元件相同或基本上相似的方式配置。例如,如上面就图3和4所描述的,外部球囊元件198可在近端194和远端196处被附着至内部球囊元件192,以便在近端194和远端196之间的每个外部球囊元件的中心区域未附着至内部球囊元件。As discussed above, the balloon member preferably has a circular cross-section to prevent or reduce the chance of deformation of the balloon member when inflated. However, other shapes may be advantageous. For example, Figures 18A and 18B illustrate an expansion device 190 similar to that shown in Figures 3 and 4, except that the inner balloon member 192 is peanut-shaped or dog-bone-shaped. That is, portions of inner balloon member 192 near proximal end 194 and distal end 196 have a wider radius than portions at the center. A plurality of outer balloon members 198 extend substantially the length of inner balloon member 192 . The outer balloon member may be configured in the same or substantially similar manner as the outer balloon member of the other embodiments. For example, as described above with respect to FIGS. 3 and 4 , outer balloon member 198 may be attached to inner balloon member 192 at proximal end 194 and distal end 196 so that each The central region of the outer balloon element is not attached to the inner balloon element.
如上面所讨论和显示,例如在图4中,外部球囊元件可配置为提供间隙,用于在邻近球囊元件之间灌注血液。当结合多个外部球囊元件使用时,形状如在图18A和18B中显示的内部球囊元件的使用可以是有优势的,因为它可允许在膨胀设备的近端和远端之间甚至更多的流动。尤其地,因为外部球囊元件198优选地未附着在中心区域,所以当膨胀时,外部球囊元件198的内表面可与内部球囊元件192间隔开,这在外部球囊元件198和内部球囊元件192之间限定另外的间隙199。这些另外的间隙199可进一步促进近端194和远端196之间的血液流动。As discussed above and shown, for example in FIG. 4 , the outer balloon member may be configured to provide a gap for perfusing blood between adjacent balloon members. The use of an inner balloon member shaped as shown in FIGS. 18A and 18B may be advantageous when used in conjunction with multiple outer balloon members because it may allow for even more space between the proximal and distal ends of the expansion device. Much flow. In particular, because the outer balloon member 198 is preferably not attached to the central region, when inflated, the inner surface of the outer balloon member 198 can be spaced apart from the inner balloon member 192, which creates a gap between the outer balloon member 198 and the inner balloon member 198. Additional gaps 199 are defined between the bladder elements 192 . These additional gaps 199 may further facilitate blood flow between the proximal end 194 and the distal end 196 .
而且,在膨胀过程期间,内部球囊元件192的狗骨形可帮助将人工瓣膜稳定在膨胀设备上。即,人工瓣膜可安装在近端194和远端196之间的人工瓣膜上,以便两个球根状或径向放大的区域的至少一部分(即,狗骨形内部球囊元件的宽部分)分别延伸超过假体设备的近端和远端。Also, the dog-bone shape of the inner balloon member 192 can help stabilize the prosthetic valve on the expansion device during the expansion process. That is, the prosthetic valve may be mounted on the prosthetic valve between the proximal end 194 and the distal end 196 so that at least a portion of the two bulbous or radially enlarged regions (i.e., the wide portion of the dog-bone-shaped inner balloon element) are respectively Extends beyond the proximal and distal ends of the prosthetic device.
当在环(例如,主动脉环)中展开人工瓣膜时,内部球囊元件192可被膨胀以将人工瓣膜稳定在膨胀设备上。通过将人工瓣膜安装在内部球囊元件192的两个球根状区域之间,人工瓣膜可牢固地保持在内部球囊元件192上。如果需要,人工瓣膜在环中的位置可被调整同时人工瓣膜牢固地安装在膨胀设备上。一旦人工瓣膜位于合适的展开位置上,一个或多个外部球囊元件198可被膨胀,如在图18B中显示的,以在该环中充分展开人工瓣膜。随着外部球囊元件198膨胀,外部球囊元件198压向人工瓣膜的内表面并造成人工瓣膜膨胀至它的展开构造。虽然遵循内部球囊元件192的曲线,在图18B中显示外部球囊元件198,但是应当理解,如果足够的压力施加至外部球囊元件198,则它们将在间隙199上方的区域处呈现更加棒状(例如,直线)的形状。When the prosthetic valve is deployed in the annulus (eg, the aortic annulus), inner balloon member 192 can be inflated to stabilize the prosthetic valve on the expansion device. By fitting the prosthetic valve between two bulbous regions of the inner balloon member 192, the prosthetic valve can be securely retained on the inner balloon member 192. If desired, the position of the prosthetic valve in the annulus can be adjusted while the prosthetic valve is securely mounted on the expansion device. Once the prosthetic valve is in the proper deployed position, one or more outer balloon members 198 can be inflated, as shown in Figure 18B, to fully deploy the prosthetic valve in the annulus. As outer balloon member 198 expands, outer balloon member 198 presses against the inner surface of the prosthetic valve and causes the prosthetic valve to expand to its expanded configuration. Although following the curve of the inner balloon member 192, the outer balloon member 198 is shown in FIG. (for example, a straight line).
图19A-19C图解膨胀设备的另一种实施方式。图19A-19C的膨胀设备190与显示在图18A和18B中的膨胀设备类似,除了代替多个外部球囊元件,存在围绕内部球囊元件192的单个外部球囊元件198。如在图18A和18B的实施方式中,内部球囊元件192可被膨胀以使假体设备稳定或固定在内部球囊元件192上(图19B)。接着,通过使外部球囊元件198膨胀,假体设备可被在环中充分展开(图19C)。尽管图19A-19C的实施方式包括狗骨形内部球囊元件192,但是它不提供如在图18A-18B中显示的间隙199,因为在该实施方式中外部球囊元件198充分围绕内部球囊元件192。19A-19C illustrate another embodiment of an expansion device. The expansion device 190 of FIGS. 19A-19C is similar to the expansion device shown in FIGS. 18A and 18B , except that instead of multiple outer balloon members, there is a single outer balloon member 198 surrounding the inner balloon member 192 . As in the embodiment of Figures 18A and 18B, the inner balloon member 192 may be inflated to stabilize or secure the prosthetic device on the inner balloon member 192 (Figure 19B). Next, the prosthetic device can be fully deployed in the annulus by inflating the outer balloon member 198 (Fig. 19C). Although the embodiment of FIGS. 19A-19C includes a dog-bone shaped inner balloon member 192, it does not provide a gap 199 as shown in FIGS. 18A-18B because the outer balloon member 198 fully surrounds the inner balloon in this embodiment. Element 192.
在其他实施方式中,可使用其他技术、设备和方法增加安装在输送设备远端处的膨胀设备的近端和远端之间的血液灌注。图20图解灌注设备或导管组件200,其包括内部管或导管202,腔204在其中经过。球囊元件206可在一部分内部管202上延伸并且假体设备208(例如,人工瓣膜)可蜷曲在球囊元件206上。外部管、外壳或导管210(外壳)可沿着至少一部分内部管202延伸。头锥体(nose cone)212可提供在内部管202的远端。球囊元件206可包括常规可膨胀球囊或一个本文描述的膨胀设备。In other embodiments, other techniques, devices, and methods may be used to increase blood perfusion between the proximal and distal ends of the expansion device mounted at the distal end of the delivery device. Figure 20 illustrates a perfusion device or catheter assembly 200 that includes an inner tube or catheter 202 through which a lumen 204 passes. A balloon member 206 can extend over a portion of the inner tube 202 and a prosthetic device 208 (eg, a prosthetic valve) can be crimped over the balloon member 206 . An outer tube, housing or conduit 210 (the housing) may extend along at least a portion of the inner tube 202 . A nose cone 212 may be provided at the distal end of the inner tube 202 . Balloon member 206 may comprise a conventional inflatable balloon or one of the inflation devices described herein.
腔204可被配置为接收引导线(未显示)。在假体设备前进至用于在体内膨胀的展开位置之后,引导线可从腔204去除(或至少从腔的远端去除)并且血液可被允许在球囊元件206的远端216和近端214之间灌注。参看图20,血液可在箭头218的方向上流动通过头锥体212和腔204。为了便于血液流出腔204,一个或多个开口220可提供在内部管202中。而且,如果外部管210位于内部管202之上,则外部管210也可包括多个开口222。优选地,外部管210中的开口222可邻近内部管202中的开口220排列或放置,以促进血液在球囊元件206的近端214流出腔。Lumen 204 may be configured to receive a guidewire (not shown). After the prosthetic device is advanced to a deployed position for expansion in the body, the guidewire can be removed from the lumen 204 (or at least from the distal end of the lumen) and blood can be allowed to pass through the distal end 216 and the proximal end of the balloon element 206. 214 between perfusion. Referring to FIG. 20 , blood can flow through nose cone 212 and lumen 204 in the direction of arrow 218 . To facilitate blood flow out of lumen 204 , one or more openings 220 may be provided in inner tube 202 . Also, if the outer tube 210 is located above the inner tube 202 , the outer tube 210 may also include a plurality of openings 222 . Preferably, the opening 222 in the outer tube 210 can be aligned or placed adjacent to the opening 220 in the inner tube 202 to facilitate the flow of blood out of the lumen at the proximal end 214 of the balloon member 206 .
图21图解图20灌注设备200的膨胀构造。如在图21中显示的,球囊元件206可被膨胀以展开假体设备208。在球囊元件206的膨胀期间,在球囊元件206的远端和近端之间的血流可被球囊元件206限制。但是,通过提供血液可流过的内通道(腔204),可减小血液流动经过通道的限制。另外,如果灌注设备200与在其他实施方式中公开的内部和外部球囊元件构造一起使用,则血液灌注可被进一步增加。FIG. 21 illustrates the perfusion device 200 of FIG. 20 in an expanded configuration. As shown in FIG. 21 , balloon member 206 may be inflated to deploy prosthetic device 208 . During inflation of balloon member 206 , blood flow between the distal and proximal ends of balloon member 206 may be restricted by balloon member 206 . However, by providing an inner channel (lumen 204) through which blood can flow, the restriction of blood flow through the channel can be reduced. Additionally, blood perfusion can be further increased if the perfusion device 200 is used with the inner and outer balloon member configurations disclosed in other embodiments.
在灌注设备200的改变中,如在图22中显示的,内部管202可包括可收缩的元件或可收缩的部分226。因此,如在图22中显示的,可收缩的元件226可接收蜷曲的假体设备208并当假体设备208蜷曲在其上时通过收缩至更小的直径实现更低的轮廓。因为当球囊元件206处于膨胀构造时(图21),主要需要血液灌注通过腔204,所以当假体设备处于收缩(蜷曲)构造时(图22),可收缩的元件226的狭窄的腔204不明显限制血流。In a variation of perfusion device 200 , inner tube 202 may include a collapsible element or collapsible portion 226 as shown in FIG. 22 . Thus, as shown in FIG. 22, the collapsible member 226 can receive the crimped prosthetic device 208 and achieve a lower profile by contracting to a smaller diameter when the prosthetic device 208 is crimped thereon. Because blood perfusion through lumen 204 is primarily required when balloon element 206 is in the expanded configuration (FIG. 21), the narrow lumen 204 of collapsible element 226 is No significant restriction of blood flow.
当对可收缩的元件226的压缩力通过使球囊元件206膨胀被去除时,可收缩的元件226期望地返回至更大的直径构造(比如图21中显示的)。常规的管材料可能无法足够恢复以允许足够的血液流动通过腔。另外,当通过蜷曲人工瓣膜的力挤压(收缩)时,或当随后在扩张期间通过球囊元件206施加的内向力膨胀时,常规的管可弯曲、断裂或以其他方式故障(fail)。因此,可收缩的元件226优选地由弹性材料,比如Nitinol(镍钛金属互化物)形成。在优选的实施方式中,可收缩的元件226包括由Nitinol形成的编织物。When the compressive force on the collapsible member 226 is removed by expanding the balloon member 206, the collapsible member 226 desirably returns to a larger diameter configuration (such as that shown in FIG. 21 ). Conventional tube materials may not recover enough to allow adequate blood flow through the lumen. Additionally, conventional tubes can bend, break or otherwise fail when squeezed (contracted) by the force of crimping the prosthetic valve, or when subsequently inflated by the inward force applied by balloon member 206 during expansion. Accordingly, the collapsible member 226 is preferably formed from a resilient material, such as Nitinol (nickel-titanium intermetallic compound). In a preferred embodiment, the collapsible element 226 comprises a braid formed from Nitinol.
如上面所讨论的,灌注腔可结合本文描述的多球囊膨胀设备使用。例如,图23和24图解膨胀设备250,其包括内部球囊元件252和多个外部球囊元件254,并且其结合内部管258的灌注腔256使用。灌注腔256在膨胀设备250的近端和远端之间延伸。图23和24的膨胀设备250基本上相同,除了图24的内部球囊元件252具有大体上花生形或狗骨形的形状,如上面就图18A和18B所描述的。应当理解,膨胀设备250可采用本文描述的任何膨胀设备的形式,并且腔256可配置为允许血液在如在本文任何实施方式中所述的膨胀设备的近端和远端之间通过。As discussed above, a perfusion lumen may be used in conjunction with the multi-balloon inflation devices described herein. For example, FIGS. 23 and 24 illustrate an expansion device 250 that includes an inner balloon member 252 and a plurality of outer balloon members 254 and that is used in conjunction with a perfusion lumen 256 of an inner tube 258 . Perfusion lumen 256 extends between proximal and distal ends of expansion device 250 . The expansion devices 250 of Figures 23 and 24 are substantially the same, except that the inner balloon member 252 of Figure 24 has a generally peanut or dog-bone shape, as described above with respect to Figures 18A and 18B. It should be appreciated that inflation device 250 may take the form of any inflation device described herein, and lumen 256 may be configured to allow passage of blood between the proximal and distal ends of the inflation device as described in any of the embodiments herein.
在其他实施方式中,膨胀设备的近端和远端之间的灌注通道可包括一个或多个腔。例如,如在图25A和25B中显示的,灌注设备或导管组件300包括管302,其具有单个腔304,用于在膨胀设备310的远端308和近端306之间血液灌注。管302中的开孔312允许血液从腔304流动。血液灌注通过腔304可以以与就图20和21上述的相同或基本上相似的方式实现。In other embodiments, the perfusion channel between the proximal and distal ends of the expansion device may include one or more lumens. For example, as shown in FIGS. 25A and 25B , a perfusion device or catheter assembly 300 includes a tube 302 having a single lumen 304 for blood perfusion between a distal end 308 and a proximal end 306 of an expansion device 310 . Openings 312 in tube 302 allow blood to flow from lumen 304 . Perfusion of blood through lumen 304 may be accomplished in the same or substantially similar manner as described above with respect to FIGS. 20 and 21 .
在图26A和26B中显示的另一种实施方式中,灌注设备或导管组件320包括管或导管322,其具有多个腔324,用于在膨胀设备330的近端326和远端328之间血液灌注。管322中的一个或多个开口332允许血液从一个或多个腔324向外流动。期望地,管322形成有与每个腔流体连通的至少一个开孔332。再一次,血液灌注通过腔324可以以与就图20和21上述的相同或基本上类似的方式实现。但是,因为有多个腔324用于血液灌注,所以可更期望包括多个可与外部杆(未显示)中的各个开口对齐的开口332。In another embodiment shown in FIGS. 26A and 26B , a perfusion device or catheter assembly 320 includes a tube or catheter 322 having a plurality of lumens 324 for connecting between a proximal end 326 and a distal end 328 of an expansion device 330 . blood perfusion. One or more openings 332 in tube 322 allow blood to flow outward from one or more lumens 324 . Desirably, tube 322 is formed with at least one aperture 332 in fluid communication with each lumen. Again, perfusion of blood through lumen 324 may be accomplished in the same or substantially similar manner as described above with respect to FIGS. 20 and 21 . However, since there are multiple lumens 324 for blood perfusion, it may be more desirable to include multiple openings 332 that may be aligned with respective openings in the outer rod (not shown).
上面的实施方式公开了用于在身体的孔或通道中展开膨胀设备的方法。通过提供允许和/或增加膨胀设备之间血液灌注的结构,医师可具有另外的展开(或收缩)膨胀设备的时间,并且可减少由于血液闭塞通过孔或通道引起的显著副作用的风险。The above embodiments disclose methods for deploying an expansion device in an orifice or passage of the body. By providing structures that allow and/or increase blood perfusion between the expansion devices, the physician may have additional time to deploy (or deflate) the expansion devices and may reduce the risk of significant side effects due to blood occlusion through the holes or passages.
公开用于将假体设备固定至输送设备的远端部的另外实施方式。图27图解使用释放线(release wire)可释放地固定假体设备的装置和设备。输送装置400包括内部管或导管402和外部管或导管404(外壳)。球囊元件406和头锥体408位于内部管402的远端处。假体设备410经延伸入假体设备410上各自开口的一条或多条绳(例如,丝)412可固定至内部管。每条绳412经过假体设备410上的开孔,并且一条或多条释放线414经过在各自绳412末端处的开孔或线圈416,以将假体设备410固定至内部管。释放线414可被连接至外部管404并且外部管404相对于内部管402的缩回(近侧移动)可造成释放线414从绳412的开口416去除,允许线圈416拉过它们在假体设备410上各自开口,并从而将假体设备410从由绳412和释放线414形成的连接释放。可选地,释放线414可近端延伸至柄(未显示)并且独立于外部管404被移动或释放。在图解的实施方式中,假体设备410包括支架的人工心脏瓣膜。为了在图中清楚,人工瓣膜的小叶被省略。Additional embodiments for securing a prosthetic device to the distal end of a delivery device are disclosed. Figure 27 illustrates devices and devices for releasably securing a prosthetic device using a release wire. The delivery device 400 includes an inner tube or catheter 402 and an outer tube or catheter 404 (housing). Balloon element 406 and nose cone 408 are located at the distal end of inner tube 402 . The prosthetic device 410 may be secured to the inner tube via one or more strings (eg, wires) 412 extending into respective openings on the prosthetic device 410 . Each string 412 passes through an aperture in the prosthetic device 410 and one or more release wires 414 pass through an aperture or coil 416 at the end of the respective string 412 to secure the prosthetic device 410 to the inner tube. The release wire 414 can be connected to the outer tube 404 and retraction (proximal movement) of the outer tube 404 relative to the inner tube 402 can cause the release wire 414 to be removed from the opening 416 of the string 412, allowing the coil 416 to be pulled through them in the prosthetic device. 410 and thereby release the prosthetic device 410 from the connection formed by the string 412 and the release wire 414 . Optionally, release wire 414 may extend proximally to a handle (not shown) and be moved or released independently of outer tube 404 . In the illustrated embodiment, the prosthetic device 410 comprises a stented prosthetic heart valve. For clarity in the figure, the leaflets of the prosthetic valve are omitted.
在图28中显示的另一种实施方式中,输送装置400包括从内部管402的远端延伸的钩元件420。钩元件420优选地向外偏,以便每个钩元件420的远端保持在假体设备410中的开孔421。为了释放假体设备410,外部管404可相对于内部管402和钩元件远侧移动,从而随着外部管经过钩元件迫使向外偏的钩元件420向内。随着向外的管404移动通过钩元件420,钩元件420被压至外部管的内直径,从而使钩元件420径向向内移动并脱离与开口421的接合。因此,通过外部管404施加至钩元件420的内向力使假体设备420从钩元件420释放。In another embodiment shown in FIG. 28 , the delivery device 400 includes a hook element 420 extending from the distal end of the inner tube 402 . The hook elements 420 are preferably biased outwardly so that the distal end of each hook element 420 remains within the aperture 421 in the prosthetic device 410 . To release the prosthetic device 410, the outer tube 404 can be moved distally relative to the inner tube 402 and hook elements, thereby forcing the outwardly deflected hook elements 420 inwardly as the outer tube passes the hook elements. As the outward tube 404 moves past the hook element 420 , the hook element 420 is pressed to the inner diameter of the outer tube, causing the hook element 420 to move radially inward and out of engagement with the opening 421 . Thus, the inward force applied to the hook element 420 by the outer tube 404 releases the prosthetic device 420 from the hook element 420 .
在其他实施方式中,假体设备可从两端固定至输送装置,以在它已经被膨胀之后提供人工瓣膜的进一步可操作性。图29示意性(在部分横截面中)图解球囊元件450,其具有用于将假体设备454固定至球囊元件450的多个固定元件452。固定元件452可包括支持襟翼(holding flap),其从球囊元件450分别向远端和近端延伸。支持襟翼可与球囊元件450整体形成或它们可以是连接(胶合、缝合等)至球囊元件450的分开的元件。随着球囊元件450缩小,固定元件452从假体设备454拉开,从而使人工瓣膜454从固定元件452释放。In other embodiments, the prosthetic device may be secured to the delivery device from both ends to provide further operability of the prosthetic valve after it has been expanded. FIG. 29 illustrates schematically (in partial cross-section) a balloon element 450 with a plurality of fixation elements 452 for securing a prosthetic device 454 to the balloon element 450 . The fixation element 452 may include holding flaps extending distally and proximally from the balloon element 450, respectively. The support flaps may be integrally formed with the balloon member 450 or they may be separate members attached (glued, sewn, etc.) to the balloon member 450 . As balloon member 450 deflates, fixation member 452 is pulled away from prosthetic device 454 , thereby releasing prosthetic valve 454 from fixation member 452 .
图30图解了一种实施方式,其中假体设备(例如,人工心脏瓣膜)在近端和远端连接至输送装置500。钩元件502(如上面所讨论的)可用于固定假体设备504的近端,而一个或多个缝合506可从输送装置500的近端延伸至假体设备504的远端。例如,缝合506可从输送装置500的近端延伸经过内部管508并向外经过位于装置500远端的头锥体510中的开口505。缝合506可从开口505延伸并环绕和围绕(或通过)假体设备504的远端部。缝合的自由端可接着返回通过内部管508延伸至输送装置500的近端。缝合506可被从输送装置500的近端释放,以释放假体设备504的远端。FIG. 30 illustrates an embodiment in which a prosthetic device (eg, a prosthetic heart valve) is connected to a delivery device 500 at proximal and distal ends. Hook elements 502 (as discussed above) can be used to secure the proximal end of the prosthetic device 504 , while one or more sutures 506 can extend from the proximal end of the delivery device 500 to the distal end of the prosthetic device 504 . For example, suture 506 may extend from the proximal end of delivery device 500 through inner tube 508 and out through opening 505 in nose cone 510 at the distal end of device 500 . Suture 506 may extend from opening 505 and around and around (or through) the distal end of prosthetic device 504 . The sutured free end may then extend back through inner tube 508 to the proximal end of delivery device 500 . Suture 506 may be released from the proximal end of delivery device 500 to release the distal end of prosthetic device 504 .
为了维持对假体设备504远端的张力,弹簧元件512可被连接至固定假体设备504的缝合506的每个末端。例如,如果使用3个缝合506固定假体设备504的远端(如在中显示图27),则缝合506环绕通过假体设备之后,缝合506的6个末端可被固定至输送装置500的近端(例如,在弹簧元件512处)。To maintain tension on the distal end of the prosthetic device 504 , a spring element 512 may be attached to each end of the suture 506 securing the prosthetic device 504 . For example, if 3 sutures 506 are used to secure the distal end of the prosthetic device 504 (as shown in FIG. 27 ), after the suture 506 is looped through the prosthetic device, the 6 ends of the suture 506 can be secured to the proximal end of the delivery device 500. end (eg, at spring element 512).
图31图解一种实施方式,其中假体设备(例如,人工心脏瓣膜)使用缝合在假体设备604的近端和远端两处被连接至输送装置600。如在图31中显示的,第一组缝合602a可从输送装置的近端延伸经过内部管606并离开位于输送装置600的远端处的头锥体610中的开口609。类似地,第二组缝合602b可在靠近人工瓣膜的区域处延伸出内部管608并固定假体设备604的近端。缝合602a和602b可以任何已知的方式被连接至假体设备604,包括例如,使用上面讨论的环绕(loops)。FIG. 31 illustrates an embodiment in which a prosthetic device (eg, a prosthetic heart valve) is attached to delivery device 600 at both the proximal and distal ends of prosthetic device 604 using sutures. As shown in FIG. 31 , a first set of sutures 602 a can extend from the proximal end of the delivery device 600 through the inner tube 606 and out the opening 609 in the nose cone 610 at the distal end of the delivery device 600 . Similarly, a second set of sutures 602b may extend out of the inner tube 608 and secure the proximal end of the prosthetic device 604 at a region proximal to the prosthetic valve. Sutures 602a and 602b may be attached to prosthetic device 604 in any known manner, including, for example, using the loops discussed above.
用于将假体设备钩住或以其他方式固定至输送装置一部分的上述结构和方法结合本文描述的多阶段膨胀结构可以是尤其有用的。随着假体设备部分膨胀,通过球囊元件施加在假体设备上的力可变化并比在充分膨胀下的力更不可预测,因此当球囊元件被膨胀至它的功能大小时其可能不足以固定或抓紧人工瓣膜。因此,当使球囊元件部分膨胀或提供用于分阶段地使人工瓣膜膨胀的系统时,固定机构比如上述那些可尤其有用,因为这种固定结构可使人工瓣膜相对于球囊元件保持在固定的位置,以确保人工瓣膜可预测的和均匀的膨胀。而且,在人工瓣膜被部分膨胀后,这种固定结构可使人工瓣膜相对于输送装置保持在固定的位置,以允许医师调整人工瓣膜(例如,近端或远端)在体腔内相对于展开位点的位置。The structures and methods described above for hooking or otherwise securing a prosthetic device to a portion of a delivery device may be particularly useful in conjunction with the multi-stage expansion structures described herein. As the prosthetic device is partially inflated, the force exerted on the prosthetic device by the balloon element can be variable and less predictable than under full expansion, so it may be insufficient when the balloon element is inflated to its functional size To hold or grasp the prosthetic valve. Therefore, fixation mechanisms such as those described above may be particularly useful when partially inflating a balloon member or providing a system for expanding a prosthetic valve in stages, since such a fixation structure can keep the prosthetic valve in a fixed position relative to the balloon member. position to ensure predictable and uniform expansion of the prosthetic valve. Moreover, after the prosthetic valve is partially expanded, this fixation structure can maintain the prosthetic valve in a fixed position relative to the delivery device to allow the physician to adjust the prosthetic valve (eg, proximal or distal end) relative to the deployed position in the body lumen. point location.
虽然本文公开的许多实施方式已经参考使假体设备,比如人工心脏瓣膜,在身体的孔或通道中膨胀进行描述,但是应当理解,本文公开的膨胀设备和灌注设备也可用于进行瓣膜成形术手术。即,在瓣膜成形术手术中,球囊元件(一个或多个)的膨胀可以在假体设备没有蜷曲在其上的情况下完成。对于植入过程上述血液灌注的相同优势将存在于不包括假体设备的瓣膜成形术手术中。While many of the embodiments disclosed herein have been described with reference to expanding a prosthetic device, such as a prosthetic heart valve, in a body bore or passageway, it should be understood that the expansion devices and perfusion devices disclosed herein may also be used to perform valvuloplasty procedures . That is, during a valvuloplasty procedure, inflation of the balloon member(s) can be accomplished without the prosthetic device being crimped thereon. The same advantages of blood perfusion described above for the implantation procedure will exist in valvuloplasty procedures that do not include a prosthetic device.
另外地,应当理解,膨胀设备不需要包括所有的球囊元件,并且可选地,可包括机械膨胀设备。例如,具有开放框架构造的机械膨胀元件可包括在其周围布置多个外部球囊元件的中心膨胀元件。Additionally, it should be understood that the expansion device need not include all of the balloon elements, and may alternatively include a mechanical expansion device. For example, a mechanical expansion element having an open frame configuration may comprise a central expansion element around which a plurality of outer balloon elements are arranged.
图32-37公开了一种具有开放框架构造的膨胀设备(可膨胀篮(expandable basket))700的图解的实施方式。膨胀设备700可包括多个纵向延伸的、圆周间隔的支柱702,其终止于膨胀设备的相对端并结合在一起。例如,如在图32中显示的,支柱702可在膨胀设备700的远端元件(杯形件)704和近端元件(杯形件)706之间延伸。支柱702可由各种材料形成并呈现各种形状,只要形状和结构足够强以使得假体设备膨胀,如在下面更详细描述的。例如,每个支柱702可由弹性材料——比如硬塑料或金属——的管状结构形成。另外,膨胀设备700可由多种数量的支柱702形成,只要支柱具有足够的数量、强度和/或形状,以便提供足够的力至假体设备的表面和/或接触点以使设备膨胀,如本文所描述的。32-37 disclose a diagrammatic embodiment of an expansion device (expandable basket) 700 having an open frame configuration. The expansion device 700 may include a plurality of longitudinally extending, circumferentially spaced struts 702 terminating at opposite ends of the expansion device and joined together. For example, as shown in FIG. 32 , strut 702 may extend between distal element (cup) 704 and proximal element (cup) 706 of expansion device 700 . Struts 702 may be formed from various materials and assume various shapes, so long as the shape and structure are strong enough to allow expansion of the prosthetic device, as described in more detail below. For example, each strut 702 may be formed from a tubular structure of a resilient material, such as hard plastic or metal. Additionally, the expansion device 700 can be formed from various numbers of struts 702, so long as the struts are of sufficient number, strength, and/or shape to provide sufficient force to the surface and/or contact points of the prosthetic device to expand the device, as described herein as described.
在操作中,远端704和近端元件706可相对彼此移动,以使膨胀设备70膨胀(通过移动靠近在一起)或收缩(通过移动进一步分开)。远端704和近端元件706的相对移动可通过例如使在每个元件之间延伸并且与每个元件螺纹连接的中心螺杆机构710平移得以实现。参看图35-37,显示使膨胀设备700膨胀的方法。为了方便,在这些图的每个中仅显示单个支柱702。另外,为了清楚,在图35和36中球囊元件被去除。图35图解收缩构造的膨胀设备700的机械部分(即,支柱702)。图36图解膨胀构造的支柱702,其中两个杯形件(远端和近端元件)704、706已经移动更靠近在一起,迫使支柱702径向膨胀。杯形件704、706的相对移动可通过例如旋转中心螺杆机构710实现。可选地,杯形件704、706可使用其他结构,比如通过拉或推附着在一个或两个杯形件704、706上的丝或棒,移动更靠近在一起(使支柱702径向膨胀)或进一步分开(使支柱702径向收缩)。In operation, distal end 704 and proximal end member 706 are movable relative to each other to expand (by moving closer together) or contract (by moving further apart) expansion device 70 . Relative movement of the distal end 704 and the proximal end element 706 may be achieved by, for example, translating a central screw mechanism 710 extending between and threadedly connected with each element. Referring to Figures 35-37, a method of expanding the expansion device 700 is shown. For convenience, only a single strut 702 is shown in each of these figures. Additionally, the balloon element has been removed in FIGS. 35 and 36 for clarity. FIG. 35 illustrates the mechanical portion of expansion device 700 (ie, strut 702 ) in a collapsed configuration. Figure 36 illustrates strut 702 in an expanded configuration, where the two cups (distal and proximal elements) 704, 706 have been moved closer together, forcing strut 702 to expand radially. Relative movement of the cups 704, 706 may be achieved by, for example, a rotating center screw mechanism 710. Alternatively, the cups 704, 706 can be moved closer together (radially expanding the struts 702) using other structures, such as by pulling or pushing a wire or rod attached to one or both cups 704, 706. ) or further apart (to radially contract struts 702).
图37图解充分膨胀构造的支柱702,外部球囊元件沿着支柱702的至少一部分表面延伸。为了清楚,其他支柱和外部球囊元件已经被去除。以膨胀构造显示支柱702,外部球囊元件708也是膨胀的。膨胀的顺序可变化。例如,内部元件(支柱702)可被膨胀并接着外部球囊元件708可被膨胀,或可选地,外部球囊元件708可被膨胀,然后膨胀内部元件(支柱702)。而且,如在图37中显示的,导管711可从膨胀设备的近端向远端延伸。经导管711中的腔输送的流体可使外部球囊元件708膨胀。FIG. 37 illustrates the strut 702 in a fully expanded configuration with the outer balloon member extending along at least a portion of the surface of the strut 702 . Other struts and outer balloon elements have been removed for clarity. Strut 702 is shown in an expanded configuration, with outer balloon member 708 also expanded. The order of expansion can vary. For example, the inner member (strut 702) can be expanded and then the outer balloon member 708 can be expanded, or alternatively, the outer balloon member 708 can be expanded followed by the inner member (strut 702). Also, as shown in Figure 37, a conduit 711 may extend from the proximal end to the distal end of the expansion device. Fluid delivered through the lumen in catheter 711 can inflate outer balloon member 708 .
多个外部球囊元件708可被与支柱702连接。每个外部球囊元件708期望地与至少一个支柱702连接,以便它可相对于支柱702保持它的位置。多个支柱702可每个具有外表面,其限定用于支撑至少一个外部球囊元件708的支撑表面。每个支柱的支撑表面的宽度可变化。例如,如果仅仅一个支柱702支撑每个外部球囊元件708,则支柱和支撑表面可具有更大的宽度。但是,如果多个支柱702支撑单个外部球囊元件708,支柱和支撑表面的宽度可较小。环形排列的每个支柱702是可横向变形的以使环形排列的支柱702以及它们限定的支撑表面径向膨胀或径向收缩。A plurality of outer balloon elements 708 may be connected to struts 702 . Each outer balloon member 708 is desirably connected to at least one strut 702 so that it can maintain its position relative to the strut 702 . Plurality of struts 702 may each have an outer surface that defines a support surface for supporting at least one outer balloon member 708 . The width of the support surface of each strut may vary. For example, if only one strut 702 supports each outer balloon member 708, the struts and support surfaces may have a greater width. However, if multiple struts 702 support a single outer balloon member 708, the width of the struts and support surfaces may be smaller. Each of the annular array of struts 702 is laterally deformable to radially expand or radially contract the annular array of struts 702 and the support surfaces they define.
在操作中,支柱702可起到与本文公开的内部球囊元件类似的作用。即,支柱702具有收缩构造(图32)和膨胀构造(图33)。图33图解膨胀构造的支柱702,其中外部球囊元件保持收缩构造。当膨胀设备700被膨胀时,支柱702的支撑表面将径向向外朝着安装在其上的假体设备(未显示)推动外部球囊元件708。In operation, struts 702 may function similarly to the inner balloon elements disclosed herein. That is, strut 702 has a collapsed configuration (FIG. 32) and an expanded configuration (FIG. 33). Figure 33 illustrates the strut 702 in an expanded configuration, with the outer balloon member maintaining the deflated configuration. When the expansion device 700 is inflated, the bearing surfaces of the struts 702 will push the outer balloon member 708 radially outward toward a prosthetic device (not shown) mounted thereon.
如在其他实施方式中所讨论的,膨胀设备可被分阶段地膨胀,比如第一阶段,其中仅支柱702被膨胀(使假体设备部分膨胀)和第二阶段,其中支柱702和外部球囊元件708被膨胀(使假体设备充分膨胀)。另外,外部球囊元件708优选地独立于膨胀设备700的机械部件(例如,支柱)可膨胀。因此,例如,当膨胀设备700的支柱702处于收缩状态(图32)或完全膨胀状态(图33)时,外部球囊元件708可被膨胀。因为外部球囊元件是独立可膨胀的,所以外部球囊元件708可在支柱702的膨胀之前或之后被膨胀。即,如在本文其他实施方式中所描述的,内部元件(支柱702)和外部元件(外部球囊元件708)的膨胀顺序可变化。As discussed in other embodiments, the expansion device may be expanded in stages, such as a first stage in which only the struts 702 are expanded (partially expanding the prosthetic device) and a second stage in which the struts 702 and the external balloon Element 708 is expanded (full expansion of the prosthetic device). Additionally, the outer balloon member 708 is preferably expandable independently of the mechanical components of the expansion device 700 (eg, struts). Thus, for example, the outer balloon member 708 may be inflated when the struts 702 of the expansion device 700 are in a collapsed state (FIG. 32) or a fully expanded state (FIG. 33). Because the outer balloon member is independently expandable, the outer balloon member 708 can be inflated either before or after inflation of the strut 702 . That is, as described in other embodiments herein, the order of inflation of the inner member (strut 702 ) and outer member (outer balloon member 708 ) may vary.
膨胀设备700在输送人工心脏瓣膜时可以是尤其有用的,因为机械支柱702提供明显的膨胀,而同时允许血液在邻近外部球囊的周围经过并通过膨胀设备700的大部分中空的内部。参看图36和37,例如,可见膨胀设备700的内区域(即,外部球囊元件708之下的区域)大部分是空白区,其允许显著的血液灌注经过膨胀设备700的该部分。相反,当内部元件是球囊元件时,内部球囊元件占据膨胀设备的大部分内部区域并阻止血液灌注经过膨胀设备的该部分。膨胀设备700也是尤其有优势的,因为它结合机械膨胀元件(例如,支柱702)的灌注能力和与球囊膨胀元件相关的高压膨胀强度。The expansion device 700 may be particularly useful in delivering prosthetic heart valves because the mechanical struts 702 provide substantial expansion while at the same time allowing blood to pass around the adjacent outer balloon and through the mostly hollow interior of the expansion device 700 . Referring to FIGS. 36 and 37 , for example, it can be seen that the inner region of the inflation device 700 (ie, the region below the outer balloon member 708 ) is mostly empty space, allowing significant blood perfusion through that portion of the inflation device 700 . Conversely, when the inner member is a balloon member, the inner balloon member occupies most of the inner area of the inflation device and prevents blood perfusion through that portion of the inflation device. Inflation device 700 is also particularly advantageous because it combines the perfusion capabilities of mechanical expansion elements (eg, struts 702 ) with the high pressure inflation strength associated with balloon expansion elements.
图38A-38C图解在天然主动脉环中展开人工心脏瓣膜的方法。参看图38A,显示输送设备720,其输送收缩构造的人工心脏瓣膜722。输送设备720可使用已知的过程输送人工瓣膜722至治疗位置。例如,假体设备可包括从Edwards Lifesciences LLC可获得的SAPIEN经导管心脏瓣膜(THV)并且人工瓣膜可通过经股或切顶(transapical)进路输送。38A-38C illustrate a method of deploying a prosthetic heart valve in a native aortic annulus. Referring to Fig. 38A, a delivery device 720 is shown, which delivers a prosthetic heart valve 722 in a collapsed configuration. Delivery device 720 may deliver prosthetic valve 722 to the treatment site using known procedures. For example, prosthetic devices may include the SAPIEN transcatheter heart valve (THV) available from Edwards Lifesciences LLC and the prosthetic valve may be delivered via a transfemoral or transapical approach.
人工瓣膜722可被安装在膨胀设备724上,其可以是例如参考图3本文描述类型的膨胀设备。人工瓣膜722在天然动脉瓣环726内可操作,以使用输送设备720展开。参看图38B,通过使膨胀设备724的内部球囊元件和外部球囊元件扩张使膨胀设备724膨胀。如通过箭头B所指示的,血液可在膨胀设备724的近端728和远端730之间流动经过通过膨胀设备724中的间隙734提供的灌注路径,如本文所描述和显示的(例如,图4)。在假体设备722在天然主动脉环726中展开之后,膨胀设备724可被收缩(缩小)并从主动脉环去除(图38C)。The prosthetic valve 722 may be mounted on an expansion device 724, which may be, for example, an expansion device of the type described herein with reference to FIG. 3 . Prosthetic valve 722 is operable within native arterial annulus 726 to be deployed using delivery device 720 . Referring to FIG. 38B , the expansion device 724 is inflated by expanding the inner balloon member and the outer balloon member of the inflation device 724 . As indicated by arrow B, blood can flow between the proximal end 728 and the distal end 730 of the inflation device 724 through the perfusion path provided by the gap 734 in the inflation device 724, as described and shown herein (e.g., FIG. 4). After the prosthetic device 722 is deployed in the native aortic annulus 726, the expansion device 724 can be deflated (deflated) and removed from the aortic annulus (Fig. 38C).
如上面所讨论的,外部球囊元件(例如,图3中的球囊元件52)的数量和大小可变化。当膨胀设备用于使人工心脏瓣膜(例如,如在中显示图40)的膨胀时,膨胀设备期望地膨胀至外部轮廓,其接合人工心脏瓣膜并使其膨胀至与天然环的解剖学结构一致的形状。因此,例如,当使人工心脏瓣膜在天然动脉瓣的环中膨胀时,可期望使人工心脏瓣膜膨胀成大体圆形的横截面形状。As discussed above, the number and size of the outer balloon elements (eg, balloon element 52 in FIG. 3 ) can vary. When the expansion device is used for expansion of a prosthetic heart valve (e.g., as shown in FIG. shape. Thus, for example, when expanding a prosthetic heart valve within the annulus of a native arterial valve, it may be desirable to expand the prosthetic heart valve to a generally circular cross-sectional shape.
一般而言,通过增加外部球囊元件52的数量,膨胀设备可实现更圆的外部轮廓。但是,大量的外部球囊元件52将通常使在邻近外部球囊元件之间形成更小间隙,其可减少穿过膨胀设备的总流动面积。因此,在一些实施方式中,膨胀设备具有具有特定方位和大小的外部球囊元件,以便膨胀设备能够使人工心脏瓣膜膨胀至大体圆形的横截面形状,同时提供穿过膨胀设备的足够大的流动面积以允许在膨胀设备的近端和远端之间足够量的血液灌注。In general, by increasing the number of outer balloon elements 52, the expansion device can achieve a more rounded outer profile. However, a large number of outer balloon elements 52 will generally result in a smaller gap between adjacent outer balloon elements, which can reduce the total flow area through the inflation device. Accordingly, in some embodiments, the expansion device has an outer balloon member oriented and sized such that the expansion device is capable of expanding the prosthetic heart valve to a generally circular cross-sectional shape while providing a sufficiently large air gap through the expansion device. flow area to allow perfusion of a sufficient volume of blood between the proximal and distal ends of the expansion device.
在一些实施方式中,当膨胀设备处于它的膨胀构造时,可期望提供穿过膨胀设备的一定量的流动面积,其基本上等于或大于被人工心脏瓣膜替换的天然瓣膜的有效孔面积(EOA)。以这种方式,与在膨胀设备放置在天然环中之前可能的血液灌注相同量的穿过天然环的血液灌注可使用处于膨胀状态的膨胀设备在天然环中实现。In some embodiments, when the expansion device is in its expanded configuration, it may be desirable to provide an amount of flow area through the expansion device that is substantially equal to or greater than the effective orifice area (EOA) of the native valve being replaced by the prosthetic heart valve. ). In this way, the same amount of blood perfusion through the native annulus can be achieved in the native annulus using the expansion device in the expanded state as was possible before the expansion device was placed in the native annulus.
如上所述的,天然动脉瓣的钙化可显著减少孔的大小。图39是在心室收缩期间(例如,以打开的状态)钙化的天然动脉瓣800的示意图。如在图39中可见的,因为天然动脉瓣800的钙化,3个天然小叶802、804、806不能完全打开,其导致天然动脉瓣800的EOA 808减小。钙化的动脉瓣的EOA一般估计在约0.5cm2和0.7cm2之间。例如,直径为约23mm的天然动脉瓣环的EOA,EOA估计为约0.56cm2并且直径为约26mm的天然动脉瓣环的EOA估计为约0.65cm2。As noted above, calcification of the native arterial valve can significantly reduce pore size. 39 is a schematic illustration of a calcified native arterial valve 800 during ventricular systole (eg, in the open state). As can be seen in FIG. 39 , the 3 native leaflets 802 , 804 , 806 cannot fully open due to calcification of the native arterial valve 800 , which results in a decrease in the EOA 808 of the native arterial valve 800 . The EOA of a calcified aortic valve is generally estimated to be between about 0.5 cm2 and 0.7 cm2 . For example, the EOA of a native arterial annulus with a diameter of about 23 mm, the EOA is estimated to be about 0.56 cm 2 and the EOA of a native arterial annulus with a diameter of about 26 mm is estimated to be about 0.65 cm 2 .
图40图解与图4中显示的膨胀设备28相似的膨胀设备810。膨胀设备810具有内部球囊元件812和7个外部球囊元件814。人工心脏瓣膜816可安装在外部球囊元件814的外表面上。如在图40中可见的,7个外部球囊元件814具有足够的数量和大小,当膨胀设备810膨胀时,外部球囊元件814压迫人工心脏瓣膜816并将它膨胀至大体圆形的横截面形状。间隙818在邻近的外部球囊元件814之间形成以提供等于或超过在图39中显示的钙化天然动脉瓣800的EOA的流动面积的总流动面积。FIG. 40 illustrates an expansion device 810 similar to the expansion device 28 shown in FIG. 4 . The expansion device 810 has an inner balloon member 812 and seven outer balloon members 814 . A prosthetic heart valve 816 may be mounted on the outer surface of the outer balloon member 814 . As can be seen in Figure 40, the seven outer balloon elements 814 are of sufficient number and size that when the expansion device 810 is inflated, the outer balloon elements 814 compress the prosthetic heart valve 816 and expand it to a generally circular cross-section shape. Gaps 818 are formed between adjacent outer balloon elements 814 to provide a total flow area equal to or exceeding that of the EOA of the calcified native arterial valve 800 shown in FIG. 39 .
因此,对于23mm的人工心脏瓣膜,设置在外部球囊元件814之间的总流动面积等于或大于约0.56cm2。对于26mm的人工心脏瓣膜,设置在外部球囊元件814之间的总流动面积等于或大于约0.65cm2。对于任何大小的天然动脉瓣,在沿着膨胀设备810长度的任何位置处的间隙的总面积优选地大于0.7cm2,以确保该流动面积等于或超过钙化天然动脉瓣的EOA的流动面积。因此,通过为血液灌注提供大于0.7cm2的总面积,在输送安装在膨胀设备810上的人工心脏瓣膜期间,患者的血流状况将不被恶化。Thus, for a 23 mm prosthetic heart valve, the total flow area disposed between outer balloon elements 814 is equal to or greater than about 0.56 cm 2 . For a 26 mm prosthetic heart valve, the total flow area disposed between outer balloon elements 814 is equal to or greater than about 0.65 cm 2 . For native arterial valves of any size, the total area of the gap at any location along the length of the expansion device 810 is preferably greater than 0.7 cm2 to ensure that the flow area equals or exceeds that of the EOA of a calcified native arterial valve. Thus, by providing a total area greater than 0.7 cm 2 for blood perfusion, the patient's blood flow conditions will not be deteriorated during delivery of a prosthetic heart valve mounted on expansion device 810 .
下面表1说明估计的通过具有7个外部球囊元件的膨胀设备实现的总流动面积。应当理解,膨胀设备的外直径对应通过膨胀设备膨胀的人工心脏瓣膜的大小。Table 1 below illustrates the estimated total flow area achieved by an inflation device with 7 outer balloon elements. It should be understood that the outer diameter of the expansion device corresponds to the size of the prosthetic heart valve expanded by the expansion device.
表1Table 1
如在上面表1中显示的,23mm和26mm人工心脏瓣膜的总流动面积可以为钙化主动脉环EOA的约两倍(例如,1.2>2(0.56)和1.8>2(0.65))。因此,在一些实施方式中,膨胀设备的总流动面积可大于钙化瓣膜EOA流动面积的约两倍。As shown in Table 1 above, the total flow area of the 23 mm and 26 mm prosthetic heart valves can be approximately twice that of the EOA of the calcified aortic annulus (eg, 1.2>2 (0.56) and 1.8>2 (0.65)). Thus, in some embodiments, the total flow area of the expansion device may be greater than about twice the flow area of the EOA of the calcified valve.
对于具有约23mm的期望膨胀大小的人工心脏瓣膜,内部球囊元件优选的直径在约10和12mm之间(更优选地约11mm)并且外部球囊元件优选的直径在约5和7mm之间(更优选地约6mm)。对于具有约26mm的期望膨胀大小的人工心脏瓣膜,内部球囊元件优选的直径在约12和14mm之间(更优选地约13mm)并且外部球囊元件优选的直径在约5和7mm之间(更优选地约6mm)。For a prosthetic heart valve with a desired expanded size of about 23 mm, the preferred diameter of the inner balloon element is between about 10 and 12 mm (more preferably about 11 mm) and the preferred diameter of the outer balloon element is between about 5 and 7 mm ( More preferably about 6mm). For a prosthetic heart valve with a desired expanded size of about 26 mm, the preferred diameter of the inner balloon element is between about 12 and 14 mm (more preferably about 13 mm) and the preferred diameter of the outer balloon element is between about 5 and 7 mm ( More preferably about 6mm).
可使用其他大小的膨胀设备,同时仍提供上述期望的流动面积。例如,人工心脏瓣膜可被设置具有比表1中显示的23mm和26mm人工心脏瓣膜更小的直径,比如20mm,和具有以表1中显示的23mm和26mm人工心脏瓣膜更大的直径,比如29mm。对于每个大小的膨胀设备,优选地设定内部球囊元件和外部球囊元件的大小以提供穿过膨胀设备的期望量的灌注。例如,在一些实施方式中,可设定每个膨胀设备的大小以提供大于约0.7cm2的流动面积量和/或大于或等于钙化瓣膜的EOA的量。Other sizes of expansion devices can be used while still providing the desired flow areas described above. For example, the artificial heart valve can be configured to have a smaller diameter than the 23mm and 26mm artificial heart valves shown in Table 1, such as 20mm, and have a larger diameter than the 23mm and 26mm artificial heart valves shown in Table 1, such as 29mm . For each size of expansion device, the inner and outer balloon members are preferably sized to provide a desired amount of perfusion through the expansion device. For example, in some embodiments, each expansion device can be sized to provide an amount of flow area greater than about 0.7 cm 2 and/or an amount of EOA greater than or equal to a calcified valve.
另外,在一些实施方式中,膨胀设备810,与本文描述的其他膨胀设备一样,可用于瓣膜成形术手术。在这种手术中,膨胀设备可配置为提供这样的外直径:其可用于在瓣膜成形术手术期间实现穿过膨胀设备的期望量的灌注。膨胀设备的外直径可一般地与上述人工心脏瓣膜的大小相同。可选地,在一些实施方式中,可期望提供膨胀至如此外直径的膨胀设备,该外直径小于用于人工心脏瓣膜膨胀的那些外直径。例如,可提供膨胀至约16mm或17mm外直径的膨胀设备。当然,如果需要,这种更小尺寸的膨胀设备也可用于使类似大小的人工心脏瓣膜膨胀。Additionally, in some embodiments, expansion device 810, like the other expansion devices described herein, may be used in a valvuloplasty procedure. In such procedures, the expansion device can be configured to provide an outer diameter that can be used to achieve a desired amount of perfusion through the expansion device during the valvuloplasty procedure. The outer diameter of the expansion device may generally be the same size as the prosthetic heart valves described above. Optionally, in some embodiments it may be desirable to provide an expansion device that expands to an outer diameter that is smaller than those used for expansion of prosthetic heart valves. For example, an expansion device may be provided that expands to an outer diameter of about 16 mm or 17 mm. Of course, such smaller sized expansion devices could also be used to inflate similarly sized prosthetic heart valves, if desired.
图41图解膨胀设备830的另一种实施方式,其配置为在天然环中使人工心脏瓣膜832膨胀。如在本文描述的其他实施方式中,内部球囊元件834被多个外部球囊元件836围绕。外部球囊元件836的一个或多个可在安装的人工心脏瓣膜832的一端或两端包括扩大的部分。为了清楚,在图41中图解具有仅两个外部球囊元件836的膨胀设备830;但是,应当理解,外部球囊元件的数量可以和在其他实施方式中公开的相同,比如图4中显示的7个球囊实施方式或图5A和5B中显示的8个球囊实施方式。FIG. 41 illustrates another embodiment of an expansion device 830 configured to expand a prosthetic heart valve 832 in a native annulus. As in other embodiments described herein, the inner balloon member 834 is surrounded by a plurality of outer balloon members 836 . One or more of the outer balloon elements 836 may include enlarged portions at one or both ends of the installed prosthetic heart valve 832 . For clarity, an expansion device 830 with only two outer balloon elements 836 is illustrated in FIG. 41; however, it should be understood that the number of outer balloon elements may be the same as disclosed in other embodiments, such as that shown in 7 balloon embodiment or the 8 balloon embodiment shown in Figures 5A and 5B.
一个或多个外部球囊元件836可具有近端扩大的部分838和远端扩大的部分840。例如,每个外部球囊元件836可具有扩大的部分838、840。可选地,并非所有的外部球囊元件836可具有扩大的部分838、840,因为少至一个外部球囊元件836具有扩大的部分838、840,可有助于将人工心脏瓣膜832保持在膨胀设备830上。One or more outer balloon members 836 may have a proximally enlarged portion 838 and a distally enlarged portion 840 . For example, each outer balloon member 836 may have enlarged portions 838,840. Optionally, not all of the outer balloon elements 836 may have enlarged portions 838, 840, as as few as one outer balloon element 836 may have enlarged portions 838, 840, which may help to maintain the prosthetic heart valve 832 in inflated on device 830.
近端和远端扩大的部分838、840之间的距离可足够大,以接收其间蜷曲的和/或膨胀的人工心脏瓣膜832的长度。以这种方式,外部球囊元件可具有花生状或哑铃状形状,其可帮助将人工心脏瓣膜832保持在两个扩大的部分838、840之间外部球囊元件836的大致平的、中心部分上。当膨胀设备830被收缩时,与扩大的部分838、840相关联的另外的材料可帮助将蜷曲构造的人工心脏瓣膜832(未显示)保持在膨胀设备830上。当膨胀设备充分膨胀时(图41),扩大的部分838、840位于邻近人工心脏瓣膜832的两个末端,从而限制人工心脏瓣膜832相对于外部球囊元件836的移动。The distance between the proximal and distal enlarged portions 838, 840 may be large enough to accommodate the length of the prosthetic heart valve 832 crimped and/or expanded therebetween. In this way, the outer balloon member can have a peanut-like or dumbbell-like shape, which can help hold the prosthetic heart valve 832 between the two enlarged portions 838, 840 of the generally flat, central portion of the outer balloon member 836. superior. The additional material associated with the enlarged portions 838, 840 can help retain the crimped configuration of the prosthetic heart valve 832 (not shown) on the expansion device 830 when the expansion device 830 is deflated. When the expansion device is fully inflated ( FIG. 41 ), the enlarged portions 838 , 840 are located adjacent the ends of the prosthetic heart valve 832 , thereby limiting movement of the prosthetic heart valve 832 relative to the outer balloon member 836 .
图42-44图解膨胀设备850的另一种实施方式。膨胀设备850也包括内部球囊元件852和多个外部球囊元件854,如在本文其他实施方式中所描述的。但是,与瓣膜接触的外部球囊元件854的部分具有长度BL。球囊长度BL也可称为球囊的“工作长度”或“工作部分”,因为它是接触并压迫人工心脏瓣膜引起人工心脏瓣膜膨胀的球囊部分。42-44 illustrate another embodiment of an expansion device 850 . The expansion device 850 also includes an inner balloon member 852 and a plurality of outer balloon members 854, as described in other embodiments herein. However, the portion of the outer balloon member 854 that is in contact with the valve has a length BL. The balloon length BL may also be referred to as the "working length" or "working portion" of the balloon because it is the portion of the balloon that contacts and compresses the prosthetic heart valve causing the prosthetic heart valve to expand.
在一些实施方式中,至少一些外部球囊元件854的工作长度BL比人工心脏瓣膜的长度VL短。通过减小外部球囊元件的工作长度BL,可实现穿过膨胀设备850的更大的血液灌注。即,血液必须流经的外部球囊元件中间隙的距离变短,这增加了穿过膨胀设备850的血流率。In some embodiments, the working length BL of at least some of the outer balloon elements 854 is shorter than the length VL of the prosthetic heart valve. By reducing the working length BL of the outer balloon member, greater blood perfusion through the inflation device 850 can be achieved. That is, the distance of the gap in the outer balloon element through which blood must flow is shortened, which increases the blood flow rate through inflation device 850 .
图43A是沿着外部球囊元件854的工作部分(即,压迫并使人工心脏瓣膜膨胀的部分)取的横截面视图。图43B是沿着外部球囊元件854的非工作部分(即,包括不压迫和使人工心脏瓣膜膨胀的减小轮廓的尾部的部分)取的横截面视图。在减小轮廓的尾部区域(即,外部球囊元件的非工作部分)可实现穿过膨胀设备850的更高的血流率,因为在该区域中邻近的外部球囊元件854之间有更大的间隙或开口,如在图43B中显示的。Figure 43A is a cross-sectional view taken along the working portion of the outer balloon member 854 (ie, the portion that compresses and expands the prosthetic heart valve). 43B is a cross-sectional view taken along the non-working portion of the outer balloon member 854 (ie, the portion including the reduced-profile tail that does not compress and expand the prosthetic heart valve). A higher blood flow rate through the inflation device 850 can be achieved in the tail region of reduced profile (i.e., the non-working portion of the outer balloon member) because there is more space between adjacent outer balloon members 854 in this region. Large gaps or openings, as shown in Figure 43B.
图44图解在较短的外部球囊元件854上膨胀的人工心脏瓣膜856。如上所述的,血液可更容易地经过由在邻近外部球囊元件854之间的间隙提供的更短的通道,从而允许更大量的血液灌注穿过膨胀设备850。FIG. 44 illustrates a prosthetic heart valve 856 inflated on a shorter outer balloon member 854 . As described above, blood can more easily travel through the shorter passage provided by the gap between adjacent outer balloon elements 854 , allowing a greater amount of blood to perfuse through inflation device 850 .
图45图解膨胀设备860的另一种实施方式。膨胀设备860也包括内部球囊元件862和多个外部球囊元件864,如在本文其他实施方式中所描述的。但是,至少一些外部球囊元件864的工作长度BL比瓣膜的长度VL的更短。如在之前的实施方式中所述的,通过减小外部球囊元件的工作长度BL,可实现穿过膨胀设备的更多血液灌注。FIG. 45 illustrates another embodiment of an expansion device 860 . The expansion device 860 also includes an inner balloon member 862 and a plurality of outer balloon members 864, as described in other embodiments herein. However, the working length BL of at least some of the outer balloon elements 864 is shorter than the length VL of the valve. As described in the previous embodiments, by reducing the working length BL of the outer balloon member, more blood perfusion through the inflation device can be achieved.
除了具有工作长度BL小于安装在膨胀设备860上人工心脏瓣膜866的长度VL的一个或多个外部球囊元件864之外,邻近的外部球囊元件864还可被纵向错开,以便它们彼此不沿着内部球囊元件862的长度对齐。因此,例如,一些外部球囊元件864可被朝着人工心脏瓣膜866的近端867移动,以便它们不直接放置在人工心脏瓣膜866的远端869下。其他外部球囊元件864可朝着人工心脏瓣膜866的远端869移动,以便它们不直接放置在人工心脏瓣膜866的近端867下。在一些实施方式中,外部球囊元件864可交替地错开,如在图45中显示的,以便邻近的外部球囊元件864交替从被移动朝着近端心脏瓣膜866的一侧至另一侧。In addition to one or more outer balloon elements 864 having a working length BL less than the length VL of a prosthetic heart valve 866 mounted on the expansion device 860, adjacent outer balloon elements 864 may also be longitudinally staggered so that they are not along the length of each other. aligned along the length of the inner balloon member 862. Thus, for example, some of the outer balloon elements 864 may be moved toward the proximal end 867 of the prosthetic heart valve 866 so that they are not placed directly under the distal end 869 of the prosthetic heart valve 866 . The other outer balloon elements 864 are movable towards the distal end 869 of the prosthetic heart valve 866 so that they are not placed directly under the proximal end 867 of the prosthetic heart valve 866 . In some embodiments, the outer balloon members 864 may be alternately staggered, as shown in FIG. .
通过提供上述错开的和/或交替的布置,可增加穿过膨胀设备860的血液灌注。另外,这种错开布置可减小膨胀设备860的收缩轮廓,这是因为需要较少的球囊材料生产具有更短工作长度的球囊。By providing a staggered and/or alternating arrangement as described above, blood perfusion through inflation device 860 may be increased. Additionally, this staggered arrangement can reduce the collapsed profile of the expansion device 860 because less balloon material is required to produce a balloon with a shorter working length.
图46图解膨胀设备870的另一种实施方式。膨胀设备870也包括内部球囊元件872和多个外部球囊元件874,如在本文其他实施方式中所描述的。图46是沿着膨胀设备纵向中心线取的膨胀设备870的横截面视图,并只显示多个外部球囊元件874的两个。FIG. 46 illustrates another embodiment of an expansion device 870 . The expansion device 870 also includes an inner balloon member 872 and a plurality of outer balloon members 874, as described in other embodiments herein. 46 is a cross-sectional view of the expansion device 870 taken along the longitudinal centerline of the expansion device and only two of the plurality of outer balloon members 874 are shown.
每个外部球囊元件874具有尾部876,其从每个外部球囊元件874的近端或远端延伸。尾部876优选地附着至内部球囊元件872的一部分,以实现当外部球囊元件874收缩和膨胀时对其更好的控制。因此,例如,尾部876可在结合点878合并至或以其他方式连接至内部球囊元件872。通过将尾部876尽可能近地附着至内部球囊元件872的主体,外部球囊元件874相对于内部球囊元件872的移动可被限制,这提供一致的膨胀设备。Each outer balloon member 874 has a tail 876 extending from either the proximal end or the distal end of each outer balloon member 874 . Tail 876 is preferably attached to a portion of inner balloon member 872 to allow for better control of outer balloon member 874 as it deflates and expands. Thus, for example, tail portion 876 may merge or otherwise connect to inner balloon member 872 at junction point 878 . By attaching the tail 876 as close as possible to the body of the inner balloon member 872, movement of the outer balloon member 874 relative to the inner balloon member 872 can be restricted, which provides a consistent inflation device.
除了如在图46中显示将外部球囊元件874的尾部876合并至和/或连接至内部球囊元件872外,在一些实施方式中,邻近的外部球囊元件874也可彼此合并和/或牢固地连接,以进一步控制外部球囊元件874相对于彼此和内部球囊元件872的移动。In addition to merging and/or connecting the tail 876 of the outer balloon member 874 to the inner balloon member 872 as shown in FIG. securely connected to further control the movement of the outer balloon member 874 relative to each other and the inner balloon member 872 .
邻近外部球囊元件的彼此连接和/或与内部球囊元件的连接可通过将球囊材料结合在一起实现。图47A和47B图解连接的尾部的实施方式。图47A图解包括内部球囊元件882和多个外部球囊元件884的膨胀设备880的尾部的横截面视图。每个外部球囊元件被固定至邻近的外部球囊元件并固定至内部球囊元件。The connection of adjacent outer balloon elements to each other and/or to the inner balloon element may be achieved by bonding the balloon materials together. 47A and 47B illustrate embodiments of linked tails. FIG. 47A illustrates a cross-sectional view of the tail of an expansion device 880 comprising an inner balloon member 882 and a plurality of outer balloon members 884 . Each outer balloon element is secured to an adjacent outer balloon element and to an inner balloon element.
在图47B中显示的实施方式中,代替简单地将尾部连接在一起,图47A显示的尾部可被合并在一起以形成具有多个腔(即,一个内部球囊腔892和7个外部球囊腔894)的集成膨胀设备890。以这种方式合并尾部可通过减少邻近球囊元件之间的移动提供对膨胀设备更好的控制。另外,通过使每个尾部合并在一起,由于在临近的合并球囊元件之间使用共用的壁部分,膨胀设备该区域的直径可从第一较大的直径φ1(图47A)减小至第二较小的直径φ2(图47B)。因此,通过如上所述将邻近球囊元件合并在一起,不仅球囊元件的相对移动可被减少和/或控制,而且膨胀设备的轮廓可被进一步减小。In the embodiment shown in FIG. 47B, instead of simply connecting the tails together, the tails shown in FIG. Lumen 894) integrated expansion device 890. Incorporating the tails in this manner may provide better control of the inflation device by reducing movement between adjacent balloon elements. Additionally, by merging each tail portion together, the diameter of this region of the inflation device can be reduced from a first larger diameter φ1 (FIG. 47A) to a second diameter due to the use of a shared wall portion between adjacent merging balloon elements. Two smaller diameters φ2 (Fig. 47B). Thus, by merging adjacent balloon elements together as described above, not only can the relative movement of the balloon elements be reduced and/or controlled, but the profile of the expansion device can be further reduced.
图48A和48B图解一种方法,其用于通过使外部球囊元件894的尾预成形为可有助于合并临近尾部的段或形状,合并膨胀元件890的尾部。例如,为了有助于合并过程,可期望将尾预成形为楔形部分,以便每个外部球囊元件可被合并至邻近它的外部球囊元件,如在图48B中显示的。可接着通过将预成形的尾部放入固定的、热金属模中将尾部合并在一起。48A and 48B illustrate one method for merging the tail of the expansion member 890 by pre-shaping the tail of the outer balloon member 894 into a segment or shape that may facilitate merging of the adjacent tail. For example, to facilitate the incorporation process, it may be desirable to pre-shape the tail into a wedge-shaped portion so that each outer balloon element can be incorporated into the outer balloon element adjacent to it, as shown in Figure 48B. The tails can then be joined together by placing the pre-formed tails into a stationary, hot metal mold.
图49、50A和50B图解膨胀设备900的另一种实施方式。膨胀设备900包括内部球囊元件902和多个外部球囊元件904。内部球囊元件902和外部球囊元件904可通过合并单个球囊的部分进行构建。因此,例如,如在图49中显示的,单个球囊可沿着多条线906被夹紧(pinch)和/或合并,以提供多个外部球囊元件904。49 , 50A and 50B illustrate another embodiment of an expansion device 900 . The expansion device 900 includes an inner balloon member 902 and a plurality of outer balloon members 904 . Inner balloon member 902 and outer balloon member 904 may be constructed by combining portions of a single balloon. Thus, for example, as shown in FIG. 49 , a single balloon may be pinched and/or merged along multiple lines 906 to provide multiple outer balloon elements 904 .
因为线906未延伸膨胀设备900的全部长度,沿着线50A-50A取的横截面仅显示在膨胀设备900近端908处的单个腔909。类似地,如果横截面在膨胀设备900远端910附近截取,它也将显示仅单个腔。由于沿着线906合并部分膨胀设备900,在膨胀设备900的近端908和远端910之间腔909分成多个腔。多个腔包括由内部球囊元件902限定的中心腔和由外部球囊元件904限定的多个腔。图50B是沿着图49中线50B-50B取的横截面视图,其显示腔909如何分成内部腔912和多个外部腔914。因为所有的腔彼此流体连通,所以当扩张流体被输送进入腔909时,扩张流体同时移动进入内部腔912和外部腔914。Because line 906 does not extend the full length of expansion device 900 , a cross-section taken along line 50A- 50A shows only a single lumen 909 at proximal end 908 of expansion device 900 . Similarly, if the cross-section was taken near the distal end 910 of the expansion device 900, it would also show only a single lumen. Between the proximal end 908 and the distal end 910 of the expansion device 900 lumen 909 splits into multiple lumens due to the incorporation of portions of the expansion device 900 along line 906 . The plurality of lumens includes a central lumen defined by inner balloon member 902 and a plurality of lumens defined by outer balloon member 904 . FIG. 50B is a cross-sectional view taken along line 50B- 50B in FIG. 49 showing how cavity 909 is divided into an inner cavity 912 and a plurality of outer cavities 914 . Because all lumens are in fluid communication with each other, when dilation fluid is delivered into lumen 909, the dilation fluid moves into inner lumen 912 and outer lumen 914 simultaneously.
本文所述膨胀设备可在瓣膜成形术手术期间提供瓣膜环的均匀径向膨胀和在瓣膜置换手术中提供人工瓣膜的均匀径向膨胀。而且,应当注意到,这种膨胀设备可在独立的瓣膜成形术手术中使用,以及在准备瓣膜置换手术中进行的瓣膜成形术手术中使用。例如,膨胀设备可用于进行瓣膜成形术手术并接着用于使假体设备在同一环中膨胀。本文所述膨胀设备可允许血液流动穿过和/或经过膨胀设备,这可允许设备被膨胀较长的持续时间并可在环中膨胀设备被膨胀的过程期间减少对起搏心脏的需要。The expansion devices described herein can provide uniform radial expansion of the valve annulus during valvuloplasty procedures and provide uniform radial expansion of prosthetic valves during valve replacement procedures. Furthermore, it should be noted that such expansion devices may be used in stand-alone valvuloplasty procedures, as well as in valvuloplasty procedures performed in preparation for valve replacement surgery. For example, an expansion device may be used to perform a valvuloplasty procedure and then used to expand a prosthetic device in the same annulus. The inflation devices described herein may allow blood to flow through and/or past the inflation device, which may allow the device to be inflated for longer durations and may reduce the need to pace the heart during the process in which the inflation device is inflated in the ring.
本文所述膨胀设备可通过使内部、中心可膨胀元件和一个或多个外部可膨胀元件膨胀,使人工瓣膜径向膨胀至横截面大致圆形的形状。常规的多个球囊膨胀设备不能够进行这种均匀的圆形膨胀,同时也提供穿过膨胀元件的足够的血液灌注。例如,具有并排放置的3个球囊元件的三球囊设备可提供血液灌注的通道,但是它将膨胀至横截面为三角——不是圆形——的形状。本文所述的膨胀设备能够膨胀成横截面是大体圆形的形状,同时允许足够的血液通过该设备。另外,本文所述膨胀设备的顺序或分阶段膨胀可允许在展开的每个阶段大体圆形展开人工瓣膜。The expansion devices described herein can radially expand a prosthetic valve to a generally circular cross-sectional shape by expanding the inner, central expandable element, and one or more outer expandable elements. Conventional multiple balloon inflation devices are not capable of such uniform circular inflation while also providing adequate blood perfusion across the inflatable element. For example, a three-balloon device with 3 balloon elements placed side by side may provide a channel for blood perfusion, but it will expand to a triangular - not circular - shape in cross-section. The expansion devices described herein are capable of expanding into a shape that is generally circular in cross-section while allowing sufficient blood to pass through the device. Additionally, sequential or staged expansion of the expansion devices described herein may allow for generally circular deployment of the prosthetic valve at each stage of deployment.
本文提供的方法和装置也包括在天然动脉瓣环中展开人工瓣膜期间用于固定假体设备的固定和稳定工具。因为左心室中存在的大量压力(substantial pressure),如图18A-19C和图27-31中显示的固定和稳定设备可用于保持人工瓣膜在膨胀设备上的适当位置。The methods and devices provided herein also include fixation and stabilization means for securing the prosthetic device during deployment of the prosthetic valve in the native arterial annulus. Because of the substantial pressure that exists in the left ventricle, fixation and stabilization devices as shown in FIGS. 18A-19C and 27-31 can be used to maintain the prosthetic valve in place on the expansion device.
虽然发明详述一般性地描述在主动脉环中展开人工瓣膜,但是应当理解,本文所述的膨胀设备可用于使其他人工瓣膜或支架在身体其他区域中膨胀,包括,例如,在冠状动脉中输送裸支架。另外,本文所述膨胀设备也可用于中心脉管系统的环或通道待被扩大——无论需要或不需要展开支架或其他假体元件——的其他医学过程。例如,本文所述膨胀设备可用于血管成形术手术中,包括例如,冠状动脉扩张手术。但是,由于上述讨论的原因,本文所述膨胀设备在瓣膜成形术和置换瓣膜手术中尤其有优势。While the Detailed Description of the Invention generally describes deploying a prosthetic valve in the aortic annulus, it should be understood that the expansion devices described herein may be used to expand other prosthetic valves or stents in other areas of the body, including, for example, in the coronary arteries Deliver the bare stent. In addition, the expansion devices described herein may also be used in other medical procedures in which an annulus or channel of the central vasculature is to be enlarged, with or without deployment of a stent or other prosthetic element. For example, expansion devices described herein may be used in angioplasty procedures, including, for example, coronary artery dilation procedures. However, for the reasons discussed above, the expansion devices described herein are particularly advantageous in valvuloplasty and replacement valve procedures.
考虑到本发明公开的原则可应用的许多可能的实施方式,应当认识到图解的实施方式仅仅是本发明优选的实施例,并且不应当认为限制本发明的范围。相反,本发明的范围由所附权利要求限定。我们因此要求我们的发明为在这些权利要求的范围和精神内的所有发明。In view of the many possible embodiments to which the principles disclosed herein may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the invention and should not be taken as limiting the scope of the invention. Rather, the scope of the invention is defined by the appended claims. We therefore claim that our inventions are all inventions within the scope and spirit of these claims.
Claims (21)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28659509P | 2009-12-15 | 2009-12-15 | |
| US61/286,595 | 2009-12-15 | ||
| PCT/US2010/060544 WO2011084500A2 (en) | 2009-12-15 | 2010-12-15 | Expansion device for treatment of vascular passageways |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102858272A CN102858272A (en) | 2013-01-02 |
| CN102858272B true CN102858272B (en) | 2015-07-15 |
Family
ID=44143789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080063892.XA Active CN102858272B (en) | 2009-12-15 | 2010-12-15 | Expansion device for treatment of vascular passageways |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20110144742A1 (en) |
| EP (1) | EP2512375B1 (en) |
| CN (1) | CN102858272B (en) |
| CA (1) | CA2784499C (en) |
| WO (1) | WO2011084500A2 (en) |
Families Citing this family (166)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006032051A2 (en) | 2004-09-14 | 2006-03-23 | Edwards Lifesciences Ag | Device and method for treatment of heart valve regurgitation |
| EP1951352B1 (en) | 2005-11-10 | 2017-01-11 | Edwards Lifesciences CardiAQ LLC | Balloon-expandable, self-expanding, vascular prosthesis connecting stent |
| WO2008013915A2 (en) | 2006-07-28 | 2008-01-31 | Arshad Quadri | Percutaneous valve prosthesis and system and method for implanting same |
| US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
| EP4541320A3 (en) | 2008-09-29 | 2025-07-09 | Edwards Lifesciences CardiAQ LLC | Heart valve |
| CA2961053C (en) | 2009-04-15 | 2019-04-30 | Edwards Lifesciences Cardiaq Llc | Vascular implant and delivery system |
| EP2429455B8 (en) | 2009-04-29 | 2021-12-15 | Edwards Lifesciences Corporation | Apparatus for replacing a diseased cardiac valve |
| US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
| US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
| US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
| WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
| US8568474B2 (en) | 2010-04-26 | 2013-10-29 | Medtronic, Inc. | Transcatheter prosthetic heart valve post-dilatation remodeling devices and methods |
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| EP4018966A1 (en) | 2010-06-21 | 2022-06-29 | Edwards Lifesciences CardiAQ LLC | Replacement heart valve |
| EP3552655B1 (en) | 2010-07-13 | 2020-12-23 | Loma Vista Medical, Inc. | Inflatable medical devices |
| US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
| US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| WO2012040655A2 (en) | 2010-09-23 | 2012-03-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
| US10188436B2 (en) | 2010-11-09 | 2019-01-29 | Loma Vista Medical, Inc. | Inflatable medical devices |
| WO2012099979A1 (en) | 2011-01-18 | 2012-07-26 | Loma Vista Medical, Inc. | Inflatable medical devices |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US12502276B2 (en) | 2011-05-16 | 2025-12-23 | Edwards Lifesciences Corporation | Inversion delivery device and method for a prosthesis |
| WO2012175483A1 (en) * | 2011-06-20 | 2012-12-27 | Jacques Seguin | Prosthetic leaflet assembly for repairing a defective cardiac valve and methods of using the same |
| US9119716B2 (en) * | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
| WO2013021375A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Percutaneous mitral valve replacement and sealing |
| WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| CA2848781C (en) | 2011-09-19 | 2018-10-23 | Boston Scientific Scimed, Inc. | Subintimal re-entry catheter and retrograde recanalization |
| EP4049626A1 (en) | 2011-12-09 | 2022-08-31 | Edwards Lifesciences Corporation | Prosthetic heart valve having improved commissure supports |
| US20130150881A1 (en) * | 2011-12-13 | 2013-06-13 | Boston Scientific Scimed, Inc. | Valvuloplasty device |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| IN2015DN02470A (en) | 2012-10-18 | 2015-09-04 | Alexander Q ; Tilson | |
| ES2934670T3 (en) | 2013-01-24 | 2023-02-23 | Cardiovalve Ltd | Ventricularly Anchored Prosthetic Valves |
| US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
| US10583002B2 (en) | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
| US9730791B2 (en) | 2013-03-14 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
| US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
| US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| US9763781B2 (en) * | 2013-05-07 | 2017-09-19 | George Kramer | Inflatable transcatheter intracardiac devices and methods for treating incompetent atrioventricular valves |
| US9511209B2 (en) * | 2013-08-06 | 2016-12-06 | Intervalve, Inc. | Bulbous balloon with mechanical pressure regulator |
| US9364642B2 (en) * | 2013-08-14 | 2016-06-14 | Invatec S.P.A. | Balloon catheter systems and methods for bypassing an occlusion in a blood vessel |
| US10004599B2 (en) | 2014-02-21 | 2018-06-26 | Edwards Lifesciences Cardiaq Llc | Prosthesis, delivery device and methods of use |
| USD755384S1 (en) | 2014-03-05 | 2016-05-03 | Edwards Lifesciences Cardiaq Llc | Stent |
| CA3161000A1 (en) | 2014-05-19 | 2015-11-26 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve with annular flap |
| US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
| WO2016016899A1 (en) | 2014-07-30 | 2016-02-04 | Mitraltech Ltd. | Articulatable prosthetic valve |
| RU2017114607A (en) | 2014-09-28 | 2018-10-29 | Кардиокинетикс, Инк. | DEVICES FOR THERAPY OF HEART FUNCTIONAL DISORDERS |
| FR3027212A1 (en) | 2014-10-16 | 2016-04-22 | Seguin Jacques | INTERVALVULAR IMPLANT FOR MITRAL VALVE |
| US10531951B2 (en) | 2014-11-26 | 2020-01-14 | Edwards Lifesciences Corporation | Transcatheter prosthetic heart valve and delivery system |
| US10226599B2 (en) | 2014-12-23 | 2019-03-12 | C.R. Bard, Inc. | Inflatable medical device and related sheath |
| US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
| CN110141399B (en) | 2015-02-05 | 2021-07-27 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with axial sliding frame |
| WO2016149653A2 (en) | 2015-03-19 | 2016-09-22 | Prytime Medical Devices, Inc. | System and method for low-profile occlusion balloon catheter |
| EP3271000B1 (en) | 2015-03-20 | 2020-06-17 | Cardiokinetix, Inc. | Systems for delivering an implantable device |
| WO2016164420A1 (en) * | 2015-04-06 | 2016-10-13 | C.R. Bard, Inc. | Inflatable perfusion balloon with outer mesh and related methods |
| US10441416B2 (en) | 2015-04-21 | 2019-10-15 | Edwards Lifesciences Corporation | Percutaneous mitral valve replacement device |
| US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
| US10226335B2 (en) | 2015-06-22 | 2019-03-12 | Edwards Lifesciences Cardiaq Llc | Actively controllable heart valve implant and method of controlling same |
| US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
| US10575951B2 (en) | 2015-08-26 | 2020-03-03 | Edwards Lifesciences Cardiaq Llc | Delivery device and methods of use for transapical delivery of replacement mitral valve |
| US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
| US10350066B2 (en) | 2015-08-28 | 2019-07-16 | Edwards Lifesciences Cardiaq Llc | Steerable delivery system for replacement mitral valve and methods of use |
| US10561496B2 (en) | 2015-09-16 | 2020-02-18 | Edwards Lifesciences Corporation | Perfusion balloon designs |
| US10314703B2 (en) * | 2015-09-21 | 2019-06-11 | Edwards Lifesciences Corporation | Cylindrical implant and balloon |
| CN113499532B (en) * | 2015-11-06 | 2024-05-28 | 巴德股份有限公司 | Perfusion balloon with selectively actuatable valve |
| EP3389557B1 (en) | 2015-12-15 | 2022-07-13 | Neovasc Tiara Inc. | Transseptal delivery system |
| US10433952B2 (en) | 2016-01-29 | 2019-10-08 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
| US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
| US11565090B2 (en) | 2016-03-04 | 2023-01-31 | C.R. Bard, Inc. | Perfusion balloon with internal valve |
| US10625058B2 (en) | 2016-03-04 | 2020-04-21 | C.R. Bard, Inc. | Perfusion balloon with external valve |
| USD815744S1 (en) | 2016-04-28 | 2018-04-17 | Edwards Lifesciences Cardiaq Llc | Valve frame for a delivery system |
| JP6408176B2 (en) | 2016-06-02 | 2018-10-17 | プリタイム・メディカル・デバイシーズ・インコーポレイテッドPrytime Medical Devices,Inc. | System and method for low profile occlusion balloon catheter |
| US10433857B2 (en) * | 2016-06-24 | 2019-10-08 | Bryan Medical, Inc. | Balloon dilation catheter |
| US10350062B2 (en) | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
| GB201613219D0 (en) | 2016-08-01 | 2016-09-14 | Mitraltech Ltd | Minimally-invasive delivery systems |
| CN120918849A (en) | 2016-08-10 | 2025-11-11 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
| CA3033666A1 (en) | 2016-08-19 | 2018-02-22 | Edwards Lifesciences Corporation | Steerable delivery system for replacement mitral valve and methods of use |
| CN109843219B (en) | 2016-08-26 | 2022-04-05 | 爱德华兹生命科学公司 | Multi-part replacement heart valve prosthesis |
| EP3519033A1 (en) | 2016-09-30 | 2019-08-07 | Boston Scientific Limited | Pouch forming catheter |
| US10758348B2 (en) | 2016-11-02 | 2020-09-01 | Edwards Lifesciences Corporation | Supra and sub-annular mitral valve delivery system |
| FR3058632B1 (en) * | 2016-11-14 | 2019-01-25 | Laboratoires Invalv | DEVICE FOR TREATING A BIOLOGICAL VALVE WITH PUSH BODY OF THE VALVE |
| CN113893064A (en) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | Methods and systems for rapid retrieval of transcatheter heart valve delivery systems |
| JP6928111B2 (en) | 2017-01-12 | 2021-09-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | Increased intravascular perfusion for critical care center |
| WO2018152556A1 (en) * | 2017-02-15 | 2018-08-23 | Strait Access Technologies Holdings (Pty) Ltd | Dilatation device |
| EP3612086A4 (en) | 2017-04-21 | 2021-01-20 | The Regents of the University of California, A California Corporation | AORTIC FLOW METER AND PUMP FOR PARTIAL AORTIC OCCLUSION |
| DE102017108521A1 (en) * | 2017-04-21 | 2018-10-25 | Biotronik Ag | Catheter device with rotatable distal tip |
| US10350395B2 (en) | 2017-06-23 | 2019-07-16 | Cook Medical Technologies Llc | Introducer for lumen support or dilation |
| WO2019010303A1 (en) | 2017-07-06 | 2019-01-10 | Edwards Lifesciences Corporation | Steerable delivery system and components |
| US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
| US10537426B2 (en) * | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
| US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
| US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
| US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
| US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
| WO2019034778A1 (en) * | 2017-08-17 | 2019-02-21 | Koninklijke Philips N.V. | Temporary occlusion balloon devices, systems and methods for preventing flow through a vascular perforation |
| CN107334564A (en) * | 2017-08-23 | 2017-11-10 | 上海纽脉太惟医疗科技有限公司 | A kind of unobstructed cardiac valves implanted medical balloon |
| CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US12458493B2 (en) | 2017-09-19 | 2025-11-04 | Cardiovalve Ltd. | Prosthetic heart valve and delivery systems and methods |
| US11304804B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve, Ltd. | Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions |
| US9895226B1 (en) | 2017-10-19 | 2018-02-20 | Mitral Tech Ltd. | Techniques for use with prosthetic valve leaflets |
| CN107951602A (en) * | 2017-12-11 | 2018-04-24 | 成都迈德克科技有限公司 | A kind of self-expanding type blood vessel dilator, erecting device and its installation method |
| GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
| GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
| WO2019147846A2 (en) | 2018-01-25 | 2019-08-01 | Edwards Lifesciences Corporation | Delivery system for aided replacement valve recapture and repositioning post- deployment |
| CN110123489A (en) * | 2018-02-02 | 2019-08-16 | 上海微创心通医疗科技有限公司 | Dilating sacculus and sacculus dilating catheter |
| CA3086610A1 (en) * | 2018-02-05 | 2019-08-08 | Minoan Medical (Pty) Limited | Airway dilation device and associated method of deployment |
| EP3749253B1 (en) | 2018-02-09 | 2023-07-05 | The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | A heart valve therapeutic device |
| US11051934B2 (en) | 2018-02-28 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic mitral valve with improved anchors and seal |
| US10918390B2 (en) * | 2018-03-30 | 2021-02-16 | DePuy Synthes Products, Inc. | Helical balloon assist device and method for using the same |
| US10786259B2 (en) | 2018-03-30 | 2020-09-29 | DePuy Synthes Products, Inc. | Split balloon assist device and method for using the same |
| WO2019195860A2 (en) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Devices and methods for anchoring transcatheter heart valve |
| EP3820380A1 (en) * | 2018-07-10 | 2021-05-19 | Boston Scientific Scimed, Inc. | Occlusive device with expandable member |
| PL238024B1 (en) * | 2018-07-24 | 2021-06-28 | American Heart Of Poland Spolka Akcyjna | System delivering implants used in structural heart diseases by a minimally invasive method |
| EP3833273A4 (en) * | 2018-08-06 | 2022-06-29 | Prytime Medical Devices, Inc. | System and method for low profile occlusion balloon catheter |
| EP3843824A1 (en) * | 2018-08-29 | 2021-07-07 | Boston Scientific Scimed Inc. | Multi-balloon pouch forming device |
| US10779946B2 (en) | 2018-09-17 | 2020-09-22 | Cardiovalve Ltd. | Leaflet-testing apparatus |
| US10595994B1 (en) | 2018-09-20 | 2020-03-24 | Vdyne, Llc | Side-delivered transcatheter heart valve replacement |
| US12186187B2 (en) | 2018-09-20 | 2025-01-07 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
| US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
| US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
| US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
| US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
| US11109969B2 (en) | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
| US11737872B2 (en) | 2018-11-08 | 2023-08-29 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
| US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
| WO2020146842A1 (en) | 2019-01-10 | 2020-07-16 | Vdyne, Llc | Anchor hook for side-delivery transcatheter heart valve prosthesis |
| US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
| US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
| GB201901887D0 (en) | 2019-02-11 | 2019-04-03 | Cardiovalve Ltd | Device for conditioning ex vivo pericardial tissue |
| AU2020231221B2 (en) | 2019-03-05 | 2025-07-31 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
| WO2020185597A1 (en) | 2019-03-08 | 2020-09-17 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
| US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
| US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
| CN113811265B (en) | 2019-04-01 | 2024-11-29 | 内奥瓦斯克迪亚拉公司 | Prosthetic valve capable of being deployed in a controlled manner |
| CN113924065B (en) | 2019-04-10 | 2026-01-30 | 内奥瓦斯克迪亚拉公司 | Prosthetic valve with natural blood flow |
| EP3952790A1 (en) | 2019-04-12 | 2022-02-16 | W.L. Gore & Associates, Inc. | Valve with multi-part frame and associated resilient bridging features |
| WO2020219459A1 (en) | 2019-04-23 | 2020-10-29 | Edwards Lifesciences Corporation | Motorized implant delivery system |
| CA3138875A1 (en) | 2019-05-04 | 2020-11-12 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
| WO2020236931A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
| WO2020247630A1 (en) * | 2019-06-07 | 2020-12-10 | Medtronic Vascular, Inc. | Balloon expandable transcatheter valve deployment devices and methods |
| EP3986332A4 (en) | 2019-06-20 | 2023-07-19 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
| CN114502104B (en) | 2019-08-05 | 2023-04-04 | 克罗瓦夫有限责任公司 | Apparatus and method for treating defective heart valves |
| CN110604607A (en) * | 2019-08-06 | 2019-12-24 | 沛嘉医疗科技(苏州)有限公司 | Shock wave device for treating calcification of heart valve |
| AU2020334080B2 (en) | 2019-08-20 | 2025-11-27 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
| JP7361205B2 (en) * | 2019-08-23 | 2023-10-13 | シー・アール・バード・インコーポレーテッド | Valvuloplasty medical device that allows blood flow during use |
| CN120531525A (en) | 2019-08-26 | 2025-08-26 | 维迪内股份有限公司 | Laterally deliverable transcatheter prosthetic valve and method for its delivery and anchoring |
| US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
| JP2023519191A (en) | 2020-03-16 | 2023-05-10 | サータス クリティカル ケア, インコーポレイテッド | BLOOD CONTROL DEVICES, SYSTEMS AND METHODS AND THEIR ERROR DETECTION |
| CN111632255B (en) * | 2020-04-28 | 2022-04-29 | 贵州省人民医院 | A kind of vasodilator tube for cardiovascular medicine and preparation method thereof |
| CN111298274B (en) * | 2020-05-14 | 2020-09-22 | 上海脉全医疗器械有限公司 | Medicine balloon and using method thereof |
| CN111588970B (en) * | 2020-05-29 | 2022-09-16 | 成都赛拉诺医疗科技有限公司 | Balloon dilatation device and manufacturing method thereof |
| CN114099909B (en) * | 2020-08-28 | 2025-03-28 | 上海纽脉医疗科技有限公司 | A balloon catheter |
| EP4192322A1 (en) * | 2020-09-27 | 2023-06-14 | Boston Scientific Scimed Inc. | Expandable guide devices, systems, and methods |
| US12357459B2 (en) | 2020-12-03 | 2025-07-15 | Cardiovalve Ltd. | Transluminal delivery system |
| WO2022132569A1 (en) | 2020-12-18 | 2022-06-23 | Edwards Lifesciences Corporation | Storage jar assembly for aprosthetic heart valve |
| CN114869401B (en) * | 2021-02-05 | 2023-09-22 | 沛嘉医疗科技(苏州)有限公司 | Shock wave device |
| US12102330B2 (en) | 2021-03-18 | 2024-10-01 | Prytime Medical Devices, Inc. | Vascular occlusion catheter for partial occlusion or full occlusion |
| AU2022377336A1 (en) | 2021-10-27 | 2024-04-11 | Edwards Lifesciences Corporation | System and method for crimping and loading a prosthetic heart valve |
| CN114515377A (en) * | 2022-03-16 | 2022-05-20 | 江苏常美医疗器械有限公司 | Balloon catheter capable of selectively expanding diameter |
| WO2024030290A1 (en) | 2022-08-01 | 2024-02-08 | Edwards Lifesciences Corporation | Inflatable balloons with flow channels |
| WO2024262526A1 (en) * | 2023-06-22 | 2024-12-26 | 株式会社カネカ | Balloon catheter |
| CN121311272A (en) * | 2023-06-22 | 2026-01-09 | 株式会社钟化 | Balloon catheter and method of balloon dilation in the balloon catheter |
| WO2025136691A1 (en) * | 2023-12-20 | 2025-06-26 | Edwards Lifesciences Corporation | Balloons for medical devices |
| WO2025197596A1 (en) * | 2024-03-22 | 2025-09-25 | 株式会社カネカ | Balloon catheter |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH668192A5 (en) * | 1985-11-29 | 1988-12-15 | Schneider Medintag Ag | CATHETER FOR TREATING NARROW BODIES, FOR EXAMPLE IN A BLOOD VESSEL. |
| US4744366A (en) * | 1986-09-10 | 1988-05-17 | Jang G David | Concentric independently inflatable/deflatable multiple diameter balloon angioplasty catheter systems and method of use |
| US4878495A (en) * | 1987-05-15 | 1989-11-07 | Joseph Grayzel | Valvuloplasty device with satellite expansion means |
| US5108370A (en) * | 1989-10-03 | 1992-04-28 | Paul Walinsky | Perfusion balloon catheter |
| US5342301A (en) * | 1992-08-13 | 1994-08-30 | Advanced Polymers Incorporated | Multi-lumen balloons and catheters made therewith |
| US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
| US5505702A (en) * | 1992-04-09 | 1996-04-09 | Scimed Life Systems, Inc. | Balloon catheter for dilatation and perfusion |
| US6623516B2 (en) * | 1992-08-13 | 2003-09-23 | Mark A. Saab | Method for changing the temperature of a selected body region |
| US5295995A (en) * | 1992-08-27 | 1994-03-22 | Kleiman Jay H | Perfusion dilatation catheter |
| US5704913A (en) * | 1993-02-16 | 1998-01-06 | Boston Scientific Corporation | Dilation catheter and method of treatment therewith |
| US5403280A (en) | 1993-02-16 | 1995-04-04 | Wang; James C. | Inflatable perfusion catheter |
| US5308356A (en) * | 1993-02-25 | 1994-05-03 | Blackshear Jr Perry L | Passive perfusion angioplasty catheter |
| US5433706A (en) * | 1993-10-25 | 1995-07-18 | Cordis Corporation | Perfusion balloon catheter |
| US5501667A (en) * | 1994-03-15 | 1996-03-26 | Cordis Corporation | Perfusion balloon and method of use and manufacture |
| US5599306A (en) * | 1994-04-01 | 1997-02-04 | Localmed, Inc. | Method and apparatus for providing external perfusion lumens on balloon catheters |
| US5658311A (en) * | 1996-07-05 | 1997-08-19 | Schneider (Usa) Inc. | High pressure expander bundle for large diameter stent deployment |
| US5947924A (en) * | 1996-09-13 | 1999-09-07 | Angiorad, L.L.C. | Dilatation/centering catheter used for the treatment of stenosis or other constriction in a bodily passageway and method thereof |
| US6117064A (en) * | 1997-01-06 | 2000-09-12 | Apple; Marc G. | Catheter system |
| EP1009467A4 (en) * | 1997-02-19 | 2001-07-25 | Condado Med Devices Corp | Multi-purpose catheters, catheter systems, and radiation treatment |
| US6280412B1 (en) * | 1999-06-17 | 2001-08-28 | Scimed Life Systems, Inc. | Stent securement by balloon modification |
| US7163504B1 (en) * | 2000-02-16 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Multi-lumen fluted balloon radiation centering catheter |
| ATE387160T1 (en) * | 2001-08-31 | 2008-03-15 | Mitral Interventions | DEVICE FOR HEART VALVE REPAIR |
| US7744620B2 (en) * | 2003-07-18 | 2010-06-29 | Intervalve, Inc. | Valvuloplasty catheter |
| US7275595B2 (en) | 2004-05-13 | 2007-10-02 | Schlumberger Technology Corporation | Method and apparatus to isolate fluids during gravel pack operations |
| US7084449B2 (en) | 2004-06-22 | 2006-08-01 | International Business Machines Corporation | Microelectronic element having trench capacitors with different capacitance values |
| US8167932B2 (en) * | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
| US8764820B2 (en) * | 2005-11-16 | 2014-07-01 | Edwards Lifesciences Corporation | Transapical heart valve delivery system and method |
| US20080021546A1 (en) * | 2006-07-18 | 2008-01-24 | Tim Patz | System for deploying balloon-expandable heart valves |
| US8663318B2 (en) * | 2007-07-23 | 2014-03-04 | Hocor Cardiovascular Technologies Llc | Method and apparatus for percutaneous aortic valve replacement |
| EP2594230B1 (en) * | 2008-02-29 | 2021-04-28 | Edwards Lifesciences Corporation | Expandable member for deploying a prosthetic device |
| WO2010042869A1 (en) | 2008-10-10 | 2010-04-15 | Intervalve, Inc. | Valvuloplasty catheter and methods |
| WO2010051025A1 (en) * | 2008-10-30 | 2010-05-06 | St. Jude Medical, Inc. | Collapsible/expandable prosthetic heart valve delivery system and methods |
-
2010
- 2010-12-15 CN CN201080063892.XA patent/CN102858272B/en active Active
- 2010-12-15 US US12/969,187 patent/US20110144742A1/en not_active Abandoned
- 2010-12-15 CA CA2784499A patent/CA2784499C/en active Active
- 2010-12-15 EP EP10842547.1A patent/EP2512375B1/en active Active
- 2010-12-15 WO PCT/US2010/060544 patent/WO2011084500A2/en not_active Ceased
-
2014
- 2014-09-02 US US14/475,341 patent/US9707078B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011084500A3 (en) | 2012-11-01 |
| WO2011084500A2 (en) | 2011-07-14 |
| EP2512375B1 (en) | 2016-12-07 |
| US9707078B2 (en) | 2017-07-18 |
| US20140371847A1 (en) | 2014-12-18 |
| EP2512375A2 (en) | 2012-10-24 |
| US20110144742A1 (en) | 2011-06-16 |
| CN102858272A (en) | 2013-01-02 |
| CA2784499C (en) | 2017-04-18 |
| CA2784499A1 (en) | 2011-07-14 |
| EP2512375A4 (en) | 2015-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102858272B (en) | Expansion device for treatment of vascular passageways | |
| US20250302616A1 (en) | Stability device for use with percutaneous delivery systems | |
| US11819403B2 (en) | Devices and systems for docking a heart valve | |
| US12280227B2 (en) | Vascular treatment devices and associated systems and methods of use | |
| US20230041152A1 (en) | Vascular treatment devices, systems, and methods of use | |
| CN108367137A (en) | Infusing balloon with selectively actuatable valve | |
| HK40055728A (en) | Devices and systems for docking a heart valve | |
| HK1260517A1 (en) | Devices and systems for docking a heart valve |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |